Drugs for Venous Insufficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(showing 155, show less)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Hesperidin |
Approved, Investigational |
Phase 4 |
|
520-26-3 |
53477767
|
Synonyms:
(2S)-Hesperidin
(S)-(−)-hesperidin
(S)-(-)-Hesperidin
7-Rhamnoglucoside, hesperetin
Atripliside b
Cirantin
Ciratin
Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-O-alpha-L-rhamnosyl-delta-glucoside) (7ci)
Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-O-a-L-rhamnosyl-D-glucoside) (7ci)
Hesper bitabs
Hesperetin 7 rhamnoglucoside
|
Hesperetin 7 rutinoside
Hesperetin 7-O-rutinoside
Hesperetin 7-rhamnoglucoside
Hesperetin-7-rutinoside
Hesperetin-rutinoside
Hesperidin
Hesperidina
Hesperidine
Hesperidoside
Hesperitin-7-rhamnoglucoside
|
|
2 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4 |
|
137-58-6 |
3676
|
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(diethylamino)-2',6'-Acetoxylidide
2-(Diethylamino)-2',6'-acetoxylidide
2-(diethylamino)-N-(2,6-Dimethylphenyl)acetamide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
a-diethylamino-2,6-Dimethylacetanilide
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
AKOS001026768
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
Alphacaine
alpha-diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-Dimethylacetanilide
alpha-Diethylamino-2,6-dimethylacetanilide
Anestacon
Anestacon Jelly
ARONIS23855
Astrazeneca brand OF lidocaine
BIDD:GT0342
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
C07073
C14H22N2O
Cappicaine
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
Cito optadren
CPD000058189
Cuivasil
D00358
Dalcaine
DB00281
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jenapharm brand OF lidocanine hydrochloride
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L0156
L1026_SIGMA
L7757_SIGMA
Lanabiotic
L-Caine
Leostesin
|
Lida-Mantle
Lidocaina
Lidocaína
Lidocaina [INN-Spanish]
lidocaine
Lidocaine
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine [USAN:INN:JAN]
Lidocaine carbonate
Lidocaine Carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine Hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
Lidocaine Monohydrochloride
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
LIDOPEN
Lignocaine
Lignocainum
Lingocaine
Lopac0_000669
Lopac-L-5647
LQZ
LS-805
Maricaine
Maybridge1_002571
MLS000069724
MLS000758263
MLS001074177
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
nchembio.65-comp16
NINDS_000174
Norwood Sunburn Spray
Novocol brand OF lidocaine hydrochloride
NSC 40030
NSC40030
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
Solarcaine aloe extra burn relief cream
Solcain
SPBio_001525
SPBio_002100
Spectrum_001118
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
STK552033
Strathmann brand OF lidocaine hydrochloride
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
α-diethylamino-2,6-dimethylacetanilide
|
|
3 |
|
Epinephrine |
Approved, Vet_approved |
Phase 4 |
|
51-43-4 |
5816
|
Synonyms:
(−)-(R)-epinephrine
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-a-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[(methylamino)methyl]-benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(−)-3,4-dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-α-((methylamino)methyl)benzyl alcohol
(-)-Adrenalin
(−)-adrenaline
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(−)-adrenaline
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-Adrenaline
(R)-Epinephrine
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51028-73-0
51-43-4
51-43-4 (FREE BASE)
A0173
AC-13188
AC1L1L7B
Acetate, epinephrine
Adnephrine
ADR ADRENALINE
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalina
Adrenalina [DCIT]
adrenaline
Adrenaline
Adrénaline
Adrenaline (JP15)
Adrenaline acid tartrate
Adrenaline bitartrate
Adrenaline hydrochloride
Adrenaline/Epinephrine
Adrenalin-Medihaler
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
ADROP
AI3-19015
Allergan brand OF adrenaline hydrochloride
Ana-Guard
Ana-kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthmahaler Mist
Asthmanefrin
Asthma-nefrin
Astmahalin
Astminhal
Balmadren
Bernarenin
BIDD:GT0119
Biorenine
bmse000316
Bosmin
Brevirenin
Bronkaid
Bronkaid mist
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
Chelafrin
CHEMBL679
CID5816
Citanest Forte
Corisol
D00095
d-Adrenaline
DB00668
D-Epifrin
D-Epinephrine
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
epinephrine
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine acetate
Epinephrine bitartrate
Epinephrine hydrochloride
Epinephrine hydrogen tartrate
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
EPIPEN E Z PEN
Epipen EZ Pen
Epipen JR
EPIPEN JR
|
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
Glaucon
Glaucosan
Glauposine
Glycirenan
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
HSCI1_000215
HSDB 4289
Hypernephrin
Hyporenin
Intranefrin
Iontocaine
IOP
Isoptoepinal
Kidoline
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
l-Epinephine
L-epinephrine
L-Epinephrine
l-Epinephrine (synthetic)
l-Epirenamine
L-Epirenamine
Levoadrenaline
Levoepinephrine
Levo-Methylaminoethanolcatechol
Levorenen
Levorenin
Levorenine
Levoreninum
l-Methylaminoethanolcatechol
L-Methylaminoethanolcatechol
Lopac-E-4642
LS-156
Lyodrin
Lyophrin
Medihaler-epi
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
nchembio747-comp9
Nephridine
Nieraline
NSC 62786
NSC62786
Paranephrin
PDSP1_001120
PDSP2_001104
Primatene
Primatene mist
Primatene Mist
R-(-)-Epinephrine
Racemic Epinephrine
Racepinephrine
R-Adrenaline
RCRA waste no. P042
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
Scurenaline
Septocaine
Simplene
Sindrenina
SMP1_000227
Soladren
Sphygmogenin
ST069368
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Susphrine
Sus-phrine
Sus-Phrine
SUS-PHRINE SULFITE-FREE
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
|
|
4 |
|
Racepinephrine |
Approved |
Phase 4 |
|
329-65-7 |
838
|
Synonyms:
(+-)-Adrenaline
(+-)-Epinephrine
2-(methylamino)-1-(3,4-Dihydroxyphenyl)ethanol
Adrenaline hydrochloride, racemic mixture
Adrenaline, racemic
Adrenaline, racemic mixture
Bird brand OF racepinefrine hydrochloride
DL-Adrenaline
Epinephrine hydrochloride, racemic mixture
Epinephrine racemic
Epinephrine, racemic
Epinephrine, racemic mixture
Hydrochloride, racepinephrine
Micronefrin
|
Micronephrine
Mixture adrenaline, racemic
Mixture epinephrine, racemic
Racemic adrenaline
Racemic epinephrine
Racemic mixture adrenaline
Racemic mixture epinephrine
Racepinefrina
Racepinefrine
Racepinefrinum
Racepinephrine
Racepinephrine hydrochloride
Vaponefrin
|
|
5 |
|
Glucosamine |
Approved, Investigational |
Phase 4 |
|
3416-24-8 |
439213
|
Synonyms:
(+)-2-amino-2-Deoxy-D-glucopyranose
(2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(2S,5R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(3R,4R,5S,6R)-3-amino-6-(Hydroxymethyl)oxane-2,4,5-triol
14257-69-3
2 amino 2 Deoxyglucose
2351-15-7
28905-10-4
2-Amino-2-deoxy-beta-D-glucopyranose
2-amino-2-deoxy-D-glucopyranose
2-amino-2-Deoxy-D-glucopyranose
2-amino-2-deoxy-D-glucose
2-amino-2-Deoxy-D-glucose
2-Amino-2-deoxy-D-glucose
2-amino-2-deoxyglucose
2-amino-2-Deoxyglucose
2-Aminoglucose
2B4D44B2-D5AC-4DA4-9BE6-A4AE9574E4A6
2-Deoxy-2-amino-D-glucose
2-Deoxy-2-aminoglucose
3416-24-8
4-04-00-02017 (Beilstein Handbook Reference)
58267-75-7
58-87-7
6490-70-6
880765-44-6
90-77-7
911653-84-4
AC1L2D1C
AC1L96WB
AC1L9B8P
AC1Q4UBH
beta-D-Glucosamine
bmse000247
BRN 1724602
BSPBio_002086
C00329
C08349
CHEBI:28393
CHEBI:47977
CHEMBL234432
chitosamine
Chitosamine
CID18897
CID439213
CID441477
Cosamin
CPD0-1193
D-(+)-Glucosamine
D04334
DB01296
|
D-glucosamine
D-Glucosamine
DivK1c_000261
Dona
Dona S
EINECS 222-311-2
Fides ecopharma brand OF glucosamine sulfate
GCS
Glucosamina
Glucosamina [INN-Spanish]
glucosamine
Glucosamine
Glucosamine (USAN/INN)
Glucosamine [USAN:INN]
Glucosamine sulfate
Glucosaminum
Glucosaminum [INN-Latin]
Hespercorbin
HMS500N03
HSDB 7469
IDI1_000261
InChI=1/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6-/m1/s1
KBio1_000261
KBio2_001311
KBio2_003879
KBio2_006447
KBio3_001306
KBioGR_000970
KBioSS_001311
LS-71671
MolPort-002-507-091
MolPort-003-944-937
NCGC00164421-01
NCGC00178826-01
nchembio.189-comp4
nchembio.2007.41-comp7
nchembio.412-comp5
NINDS_000261
Opfermann brand OF glucosamine sulfate
partially N-deacetylated poly-beta-1,6-N-acetyl-D-glucosamine
Rottapharm brand OF glucosamine sulfate
SPBio_000477
Spectrum_000831
Spectrum2_000519
Spectrum3_000443
Spectrum4_000565
Spectrum5_000756
STK801823
Sulfate, glucosamine
Viartril-S
Xicil
|
|
6 |
|
Calcium |
Approved, Nutraceutical |
Phase 4 |
|
7440-70-2 |
271
|
Synonyms:
Blood coagulation factor XIII
Ca
Ca(2+)
Ca2+
Calcio
Calcium
Calcium element
CALCIUM ion
Calcium, doubly charged positive ion
Calcium, elemental
Coagulation factor XIII
Elemental calcium
Factor XIII
|
Factor XIII a chain
Factor XIII a-chain
Factor XIII transamidase
Factor XIII, coagulation
Fibrin stabilizing factor
Fibrinase
Kalzium
Laki lorand factor
Laki-lorand factor
Stabilizing factor, fibrin
Transamidase, factor XIII
XIII, coagulation factor
|
|
7 |
|
Serine |
Approved, Nutraceutical |
Phase 4 |
|
56-45-1 |
5951
|
Synonyms:
(-)-Serine
(2S)-2-amino-3-Hydroxypropanoate
(2S)-2-amino-3-Hydroxypropanoic acid
(S)-(-)-Serine
(S)-2-amino-3-Hydroxypropanoate
(S)-2-amino-3-Hydroxy-propanoate
(S)-2-amino-3-Hydroxypropanoic acid
(S)-2-amino-3-Hydroxy-propanoic acid
(S)-2-Amino-3-hydroxypropanoic acid
(S)-a-amino-b-Hydroxypropionate
(S)-a-amino-b-Hydroxypropionic acid
(S)-alpha-amino-beta-Hydroxypropionate
(S)-alpha-amino-beta-Hydroxypropionic acid
(S)-b-amino-3-Hydroxypropionate
(S)-b-amino-3-Hydroxypropionic acid
(S)-beta-amino-3-Hydroxypropionate
(S)-beta-amino-3-Hydroxypropionic acid
(S)-Serine
(S)-α-amino-β-hydroxypropionate
(S)-α-amino-β-hydroxypropionic acid
2-amino-3-Hydroxypropanoate
2-amino-3-Hydroxypropanoic acid
3-Hydroxy-L-alanine
|
alpha-Amino-beta-hydroxypropionic acid
beta-Hydroxyalanine
beta-Hydroxy-L-alanine
b-Hydroxyalanine
b-Hydroxy-L-alanine
L Serine
L-(-)-Serine
L-2-amino-3-Hydroxypropionate
L-2-amino-3-Hydroxypropionic acid
L-3-Hydroxy-2-aminopropionate
L-3-Hydroxy-2-aminopropionic acid
L-3-Hydroxy-alanine
L-Ser
L-Serin
L-Serine
S
Ser
Serina
Serine
SERINE
Serinum
β-hydroxyalanine
β-hydroxy-L-alanine
|
|
8 |
|
Coumarin |
Experimental |
Phase 4 |
|
91-64-5 |
323
|
Synonyms:
{2h-benzo[b]pyran-2-one}
1, 2-Benzopyrone
1,2-benzopyrone
1,2-Benzopyrone
2H-1-benzopyran-2-one
2H-1-Benzopyran-2-one
2H-benzo(b)pyran-2-one
2H-benzo[b]Pyran-2-one
2H-Chromen-2-one
2H-Chromen-2-one (acd/name 4.0)
2-oxo-1,2-Benzopyran
2-oxo-2H-1-Benzopyran
2-Propenoate, 3-(2-hydroxyphenyl)-, delta-lactone
2-Propenoate, 3-(2-hydroxyphenyl)-, D-lactone
2-Propenoate, 3-(2-hydroxyphenyl)-, δ-lactone
2-Propenoic acid, 3-(2-hydroxyphenyl)-, delta-lactone
2-Propenoic acid, 3-(2-hydroxyphenyl)-, D-lactone
2-Propenoic acid, 3-(2-hydroxyphenyl)-, δ-lactone
5,6-benzo-2-Pyrone
5,6-benzo-alpha-Pyrone
|
benzo-alpha-Pyrone
benzo-a-Pyrone
benzo-α-pyrone
cis-O-Coumarinate lactone
cis-O-Coumarinic acid lactone
Coumarine
Coumarinic anhydride
Coumarinic lactone
Cumarin
Kumarin
O-Hydroxycinnamate delta-lactone
O-Hydroxycinnamate lactone
O-Hydroxycinnamate δ-lactone
O-Hydroxycinnamic acid delta-lactone
O-Hydroxycinnamic acid lactone
O-Hydroxycinnamic acid δ-lactone
O-Hydroxycinnamic lactone
O-Hydroxyzimtsaure-lacton
Rattex
Tonka bean camphor
|
|
9 |
|
Troxerutin |
Investigational |
Phase 4 |
|
7085-55-4 |
5486699
|
Synonyms:
3',4',7-Trihydroxyethylrutin
3',4',7-Tri-O-(b-hydroxyethyl)rutoside
3',4',7-Tris(hydroxyethyl)rutin
3',4',7-Tris(O-(2- hydroxyethyl))rutin
3,5-Dihydroxy-3',4',7-tris(2-hydroxyethoxy)flavone 3-rutinoside
3-[6-O-(6-Deoxy-a-L-mannopyranosyl)-b-D-glucopyranoside]3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)-flavone
3-[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-delta-glucopyranoside]3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)-flavone
Factor P-zyma
Flavonoid
Oxerutin
Paroven
Posorutin
Relvene
Rhéoflux
Rufen-P4
Ruven
Teboven
THR
TriHER
Trioxyethylrutin
Tris(hydroxyethyl)rutin
|
Tris(hydroxyethyl)rutoside
Tris-O-(2-hydroxyethyl)rutin
Tris-O-(b-hydroxyethyl)rutoside
Troxerutin
Troxerutina
Troxerutine
Troxérutine mazal
Troxerutin-ratiopharm
Troxeven
Vastribil
Veinamitol
Veniten
Veniten retard
veno SL
Venorutin
Venoruton
Venoruton P4
Venotrulan trox
Vitamin P4
Z 6000
|
|
10 |
|
Heparinoids |
|
Phase 4 |
|
|
|
11 |
|
Aminaftone |
|
Phase 4 |
|
|
|
12 |
|
Calcium, Dietary |
|
Phase 4 |
|
|
|
13 |
|
Rosuvastatin Calcium |
|
Phase 4 |
|
147098-20-2 |
|
14 |
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
|
Phase 4 |
|
|
|
15 |
|
Anticholesteremic Agents |
|
Phase 4 |
|
|
|
16 |
|
Central Nervous System Depressants |
|
Phase 4 |
|
|
|
17 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
18 |
|
Antithrombin III |
|
Phase 4 |
|
|
|
19 |
|
HIV Protease Inhibitors |
|
Phase 4 |
|
|
|
20 |
|
protease inhibitors |
|
Phase 4 |
|
|
|
Synonyms:
|
21 |
|
Serine Proteinase Inhibitors |
|
Phase 4 |
|
|
|
22 |
|
Antithrombins |
|
Phase 4 |
|
|
|
23 |
|
Factor Xa Inhibitors |
|
Phase 4 |
|
|
|
24 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
25 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
26 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
27 |
|
Sympathomimetics |
|
Phase 4 |
|
|
|
28 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
29 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
30 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
31 |
|
Adrenergic alpha-Agonists |
|
Phase 4 |
|
|
|
32 |
|
Adrenergic beta-Agonists |
|
Phase 4 |
|
|
|
33 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
34 |
|
Epinephryl borate |
|
Phase 4 |
|
|
|
35 |
|
Peripheral Nervous System Agents |
|
Phase 4 |
|
|
|
36 |
|
Mydriatics |
|
Phase 4 |
|
|
|
37 |
|
Anti-Asthmatic Agents |
|
Phase 4 |
|
|
|
38 |
|
Vasoconstrictor Agents |
|
Phase 4 |
|
|
|
39 |
|
Autonomic Agents |
|
Phase 4 |
|
|
|
40 |
|
Bronchodilator Agents |
|
Phase 4 |
|
|
|
41 |
|
Anticoagulants |
|
Phase 4 |
|
|
|
42 |
|
Fibrinolytic Agents |
|
Phase 4 |
|
|
|
43 |
|
Lipid Regulating Agents |
|
Phase 4 |
|
|
|
44 |
|
Hypolipidemic Agents |
|
Phase 4 |
|
|
|
45 |
|
Antimetabolites |
|
Phase 4 |
|
|
|
46 |
|
Glucuronyl glucosamine glycan sulfate |
|
Phase 4 |
|
|
|
47 |
|
Hypoglycemic Agents |
|
Phase 4 |
|
|
|
48 |
|
carbamide peroxide |
Approved |
Phase 2, Phase 3 |
|
124-43-6 |
|
Synonyms:
|
49 |
|
Heparin |
Approved, Investigational |
Phase 3 |
|
9005-49-6 |
46507594
772
|
Synonyms:
101921-26-0
102785-31-9
102-94-3
104521-37-1
11078-24-3
11129-39-8
12656-11-0
37324-73-5
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
Allocinnamic acid
alpha-Heparin
Alpha-Heparin
Ardeparin
Ardeparin sodium
Ariven
Arteven
Bemiparin
Bemiparin sodium
Calcilean
Calciparine
Certoparin
CID8784
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
Clexane
Clivarin
Clivarine
CY 216
Cy 222
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
Enoxaparin
Enoxaparin sodium
Eparina
Eparina [DCIT]
Fluxum
FR 860
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
Hed-heparin
Hed-Heparin
Hep Flush Kit in plastic container
Hepalean
heparin
Heparin Cy 216
Heparin CY 216
Heparin Leo
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
Heparin sodium 25,000 units in dextrose 5%
|
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sodium salt
Heparin sulfate
Heparin sulphate
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Hep-Lock
Hep-Lock U/P
HSDB 3094
Innohep
Inno-Hep
Isocinnamic acid
Kabi 2165
KB 101
Leparan
LHN 1
Lioton 1000
Lipo-hepin
Lipo-Hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Low molecular weight heparin sodium
Minolteparin sodium
MolPort-003-760-257
Multiparin
Nadroparin
Nadroparine
Novoheparin
NSC174025
Octaparin
OP 386
OP 622
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
Unfractionated heparin
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Vetren
Vitrum AB
WY 90493RD
|
|
50 |
|
tannic acid |
Approved |
Phase 3 |
|
1401-55-4 |
|
Synonyms:
ácido tánico
Gallotannic acid
|
|
|
51 |
|
Dalteparin |
Approved |
Phase 3 |
|
9005-49-6 |
|
Synonyms:
|
52 |
|
Tinzaparin |
Approved |
Phase 3 |
|
9005-49-6, 9041-08-1 |
25244225
|
Synonyms:
101921-26-0
102785-31-9
102-94-3
104521-37-1
11078-24-3
11129-39-8
12656-11-0
37324-73-5
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
Allocinnamic acid
alpha-Heparin
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
Certoparin
CID8784
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
Clivarin
Clivarine
CY 216
Cy 222
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
Enoxaparin sodium
Eparina
Eparina [DCIT]
Fluxum
FR 860
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
Hed-heparin
Hep Flush Kit in plastic container
heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
|
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Hep-Lock
Hep-Lock U/P
HSDB 3094
Innohep
Inno-Hep
Isocinnamic acid
Kabi 2165
KB 101
LHN 1
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
Nadroparin
Nadroparine
Novoheparin
NSC174025
Octaparin
OP 386
OP 622
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Tinzaparina
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Vetren
Vitrum AB
WY 90493RD
|
|
53 |
|
Benzocaine |
Approved, Investigational |
Phase 3 |
|
94-09-7, 1994-09-7 |
2337
|
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-aminobenzoic acid ethyl ester
4-amino-benzoic acid ethyl ester
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
Acetate, benzocaine
Acetate, Benzocaine
AE-562/40377256
Aethoform
Aethylium paraminobenzoicum
AI3-02081
AKOS000119763
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
AR-1H9065
Baby anbesol
Baby Anbesol
BB_SC-0019
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
benzocaine
Benzocaine
Benzocaine (USP/INN)
Benzocaine [INN:BAN]
Benzocaine acetate
Benzocaine Acetate
Benzocaine formate
Benzocaine Formate
Benzocaine hydrobromide
Benzocaine Hydrobromide
Benzocaine hydrochloride
Benzocaine Hydrochloride
Benzocaine methanesulfonate
Benzocaine Methanesulfonate
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
C07527
CAS-94-09-7
Caswell No. 430A
CHEBI:116735
CHEMBL278172
Chloraseptic
CID2337
D001566
D00552
DB01086
Dermoplast
Diet ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
|
Ethyl aminobenzoic acid
Ethyl PABA
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl P-aminobenzoate
Ethyl P-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylate
Ethyl P-aminophenylcarboxylic acid
ethylaminobenzoate-4
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny P-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
ETHYL-P-AMINOBENZOATE
Formate, benzocaine
Formate, Benzocaine
h-4-abz-oet
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, benzocaine
Hydrobromide, Benzocaine
Hydrochloride, benzocaine
Hydrochloride, Benzocaine
I05-0204
Identhesin
IDI1_000932
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
Methanesulfonate, benzocaine
Methanesulfonate, Benzocaine
MLS001331704
MLS002153970
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
nchembio.182-comp4
NINDS_000932
Norcain
Norcaine
Norcainum
NSC 122792
NSC 41531
NSC41531
NSC4688
Oprea1_750694
Oprea1_827402
Orabase-b
Ora-jel
Orthesin
Otocain
Outgro
p-(Ethoxycarbonyl)aniline
P-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
P-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
Parathesin
Parathesin (TN)
Parathesine
p-Carbethoxyaniline
P-Carbethoxyaniline
p-Ethoxycarboxylic aniline
P-Ethoxycarboxylic aniline
Prestwick_991
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Slim mint gum
SMR000059025
Solarcaine
Solu H
SPBio_000134
SPBio_002844
Spectrum_000074
SPECTRUM1500139
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
STK043620
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
|
|
54 |
|
Becaplermin |
Approved, Investigational |
Phase 3 |
|
165101-51-9 |
|
Synonyms:
165101-51-9
Becaplermin
Becaplermin (USAN/INN)
D03065
PDGF-2
PDGFB
PDGF-BB
Platelet-derived growth factor BB, recombinant
|
Platelet-derived growth factor beta polypeptide
Recombinant platelet-derived growth factor BB
Regranex
Regranex (TN)
rhPDGF-BB
rPDGF-BB
SH-POLYPEPTIDE-59
|
|
55 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
56 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 2, Phase 3 |
|
2921-57-5 |
|
Synonyms:
Methylprednisolone hydrogen succinate
|
Methylprednisolone succinate
|
|
57 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
83-43-2 |
6741
|
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
1-dehydro-6alpha-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6a-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6-alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6-Methylprednisolone
6α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-wyeth
Artisone-Wyeth
Besonia
Bio-0658
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
delta(1)-6alpha-Methylhydrocortisone
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
Lemod
LMST02030178
LS-118498
M0639_SIGMA
M1665
Medesone
Medixon
Medlone 21
Medrate
Medric acid
|
Medrol
Medrol (TN)
Medrol adt pak
Medrol Adt Pak
Medrol dosepak
Medrol Dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
MEPRDL
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
methylprednisolone
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
methylprenisolone
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metilprednisolone [DCIT]
Metipred
Metrisone
Metrocort
Metysolon
MLS000028541
MLS001148159
MLS002207191
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
Nirypan
Noretona
NSC19987
NSC-19987
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick_622
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Promacortine
Reactenol
S1733_Selleck
SAM002589984
Sieropresol
SMR000058330
Solomet
SPBio_002377
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
δ(1)-6a-methylhydrocortisone
δ(1)-6α-methylhydrocortisone
|
|
58 |
|
Zoledronic Acid |
Approved |
Phase 2, Phase 3 |
|
118072-93-8 |
68740
|
Synonyms:
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonate
(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonate
(1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid
(1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate
[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)
118072-93-8
2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid
2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
AC-1092
AC1L2ACJ
AC1Q6RN3
ácido zoledrónico
Aclasta
AKOS005145739
Anhydrous Zoledronic Acid
BIDD:GT0292
BIDD:PXR0134
Bio-0112
Bisphosphonate 3
C088658
CGP 42446
CGP 42'446
CGP 42446A
CGP-42446
CGP-42'446
CHEBI:46557
CHEMBL924
CID68740
|
D08689
DB00399
FT-0082657
HMS2089O09
I06-0710
KS-1132
LS-181815
MolPort-002-885-874
MolPort-003-850-890
NCGC00159521-02
NCGC00159521-03
Novartis brand of zoledronic acid
Novartis brand OF zoledronic acid
NSC721517
Reclast
Reclast (TN)
S00092
S1314_Selleck
UNII-70HZ18PH24
Zol
ZOL
Zoledronate
Zoledronic acid
Zoledronic acid (INN)
Zoledronic acid [USAN:INN]
Zoledronic Acid Anhydrous
Zoledronic Acid, Anhydrous
Zometa
Zometa (Novartis)
Zometa (TN)
Zometa Concentrate
Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid
|
|
59 |
|
Prednisolone |
Approved, Vet_approved |
Phase 2, Phase 3 |
|
50-24-8 |
5755
|
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-pregnadiene-3,20-dione-11β,17α,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11b,17a,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Bio-0666
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
Codelcortone
Co-Hydeltra
CO-Hydeltra
component of Ataraxoid
component of K-Predne-Dome
Cordrol
Cortalone
Cotogesic
Cotolone
CPD000718761
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
delta(1)-Cortisol
delta(1)-Dehydrocortisol
Delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
Delta(1)-dehydrohydrocortisone
Delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
Delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Deltacortenol
Deltacortril
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
Delta-Ef-Cortelan
delta-hydrocortisone
Deltahydrocortisone
Deltasolone
Delta-stab
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
Derpo PD
Dexa-Cortidelt hostacortin H
Dexa-Cortidelt Hostacortin H
Di adreson F
Di Adreson F
Di-adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Di-Adreson-F
Dicortol
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
EINECS 200-021-7
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
Hostacortin H
HSDB 3385
Hydeltra
Hydeltrasol
Hydeltra-Tba
Hydeltrone
|
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
Inflamase Forte
Inflamase Mild
I-Pred
K 1557
Key-Pred
Klismacort
Lentosone
Lite Pred
LMST02030179
LS-7669
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
Methylprednisolone Acetate
Meticortelone
Meti-Derm
Metreton
MLS001304083
MLS002154250
MLS002207037
MolPort-002-507-147
M-Predrol
NCGC00179649-01
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
NSC 9120
NSC9120
NSC9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
PRDL
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
prednisolone
Prednisolone
Prednisolone (anhydrous)
Prednisolone (JP15/USP/INN)
Prednisolone [INN:BAN:JAN]
Prednisolone acetate
Prednisolone Acetate
Prednisolone sodium phosphate
Prednisolone Sodium Phosphate
Prednisolone tebutate
Prednisolone Tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick_404
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Rolisone
S1737_Selleck
SAM002264639
Scherisolon
SMR000718761
Solone
SPBio_002367
Steran
Sterane
Sterolone
Supercortisol
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-hydrogen
Ultracortene-Hydrogen
UNII-9PHQ9Y1OLM
ZINC03833821
δ(1)-dehydrocortisol
δ(1)-dehydrohydrocortisone
δ(1)-hydrocortisone
|
|
60 |
|
Nitric Oxide |
Approved |
Phase 3 |
|
10102-43-9 |
145068
|
Synonyms:
(.)NO
(no)(.)
(NO)(.)
[no]
[NO]
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous nitrate vasodilator
Endogenous Nitrate Vasodilator
Endothelium-derived nitric oxide
Endothelium-Derived Nitric Oxide
endothelium-derived relaxing factor
Endothelium-derived relaxing factor
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, mononitrogen
Monoxide, Mononitrogen
Monoxide, nitrogen
Monoxide, Nitrogen
monoxido de nitrogeno
monoxido De nitrogeno
Monóxido de nitrógeno
monoxyde d'azote
Monoxyde d'azote
Nitrate vasodilator, endogenous
Nitrate Vasodilator, Endogenous
|
nitric oxide
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, endothelium derived
Nitric Oxide, Endothelium Derived
Nitric oxide, endothelium-derived
Nitric Oxide, Endothelium-Derived
NITRIC-OXIDE
nitrogen monooxide
Nitrogen monooxide
nitrogen monoxide
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
nitrosyl
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
NO
no(.)
NO(.)
OHM 11771
Oxide, nitric
Oxide, Nitric
oxido de nitrogeno(II)
oxido De nitrogeno(II)
óxido de nitrógeno(II)
oxido nitrico
oxido Nitrico
óxido nítrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, endogenous nitrate
Vasodilator, Endogenous Nitrate
|
|
61 |
|
Thrombin |
Approved, Investigational |
Phase 3 |
|
|
|
Synonyms:
coagulation factor II
Thrombin bovine
|
Thrombin, Topical (Bovine)
|
|
62 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 2, Phase 3 |
|
2920-86-7 |
|
Synonyms:
(+)-prednisolone hemisuccinate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
Prednisolone hydrogen succinate
Prednisolone succinate
|
|
63 |
|
Antioxidants |
|
Phase 3 |
|
|
|
64 |
|
Protective Agents |
|
Phase 2, Phase 3 |
|
|
|
65 |
|
Anti-Inflammatory Agents |
|
Phase 2, Phase 3 |
|
|
|
66 |
|
calcium heparin |
|
Phase 3 |
|
|
|
67 |
|
Tin Fluorides |
|
Phase 3 |
|
|
|
68 |
|
Hormones |
|
Phase 2, Phase 3 |
|
|
|
69 |
|
Gastrointestinal Agents |
|
Phase 2, Phase 3 |
|
|
|
70 |
|
Carboxymethylcellulose Sodium |
|
Phase 3 |
|
|
|
71 |
|
Heparin, Low-Molecular-Weight |
|
Phase 3 |
|
|
|
72 |
|
Mitogens |
|
Phase 3 |
|
|
|
73 |
|
Angiogenesis Modulating Agents |
|
Phase 3 |
|
|
|
74 |
|
Angiogenesis Inducing Agents |
|
Phase 3 |
|
|
|
75 |
|
Antiemetics |
|
Phase 2, Phase 3 |
|
|
|
76 |
|
Neuroprotective Agents |
|
Phase 2, Phase 3 |
|
|
|
77 |
|
glucocorticoids |
|
Phase 2, Phase 3 |
|
|
|
78 |
|
Methylprednisolone Acetate |
|
Phase 2, Phase 3 |
|
|
|
79 |
|
Diphosphonates |
|
Phase 2, Phase 3 |
|
|
|
80 |
|
Antineoplastic Agents, Hormonal |
|
Phase 2, Phase 3 |
|
|
|
81 |
|
Hormone Antagonists |
|
Phase 2, Phase 3 |
|
|
|
82 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Phase 2, Phase 3 |
|
|
|
83 |
|
Prednisolone acetate |
|
Phase 2, Phase 3 |
|
|
|
84 |
|
Bone Density Conservation Agents |
|
Phase 2, Phase 3 |
|
|
|
85 |
|
Free Radical Scavengers |
|
Phase 3 |
|
|
|
86 |
|
Endothelium-Dependent Relaxing Factors |
|
Phase 3 |
|
|
|
87 |
|
Vasodilator Agents |
|
Phase 3 |
|
|
|
88 |
|
Hemostatics |
|
Phase 3 |
|
|
|
89 |
|
Coagulants |
|
Phase 3 |
|
|
|
90 |
|
Grape |
Approved |
Phase 2 |
|
|
|
91 |
|
Sodium citrate |
Approved, Investigational |
Phase 1, Phase 2 |
|
68-04-2 |
|
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
|
Sodium citrate, anhydrous
Sodium citrate,anhydrous
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
92 |
|
Timolol |
Approved |
Phase 2 |
|
26839-75-8 |
33624
5478
|
Synonyms:
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-timolol
131628-37-0
194288-09-0
26839-75-8
26921-17-5 (maleate (1:1) salt)
AB00513729
AC1L1PYN
AC1Q59QM
Apo-Timol
Apo-Timop
Aquanil
Betim
Betimol
Betimol (TN)
BIDD:GT0073
Blocadren
BPBio1_001008
BRD-K08806317-050-03-6
BSPBio_000916
C07141
C13H24N4O3S
CAS-26921-17-5
CHEBI:9599
CHEMBL499
CID33624
CPD001456519
D08600
DB00373
DB08625
EINECS 248-032-6
HMS2089I11
HSDB 6533
Istalol
L-714,465
Lopac0_001189
Lopac-T-6394
LS-122231
MK-950
NCGC00016038-01
NCGC00016038-02
|
NCGC00016798-01
NCGC00016798-07
NCGC00022033-02
NCGC00022033-04
NCGC00022033-05
Novo-Timol
Nu-Timolol
Oprea1_640981
Optimol
Phoxal-timolol
Prestwick0_000948
Prestwick1_000948
Prestwick2_000948
Prestwick3_000948
Proflax
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
S(-)-Timolol maleate
SAM002564238
SPBio_003075
ST072193
Temserin
Tenopt
TIM
Timacar
Timacor
Tim-AK
timolol
Timolol
Timolol (INN)
Timolol (TN)
Timolol [USAN]
Timolol anhydrous
Timolol GFS
Timolol maleate
Timolol Maleate, (1:1) Salt
Timololo
Timololum
Timololum [INN-Latin]
Timopic
Timoptic
Timoptic in Ocudose
Timoptic OcuDose
Timoptic-XE
Timoptol
Tocris-0649
UNII-817W3C6175
|
|
93 |
|
Methyl salicylate |
Approved, Vet_approved |
Phase 2 |
|
119-36-8 |
4133
|
Synonyms:
2-(Methoxycarbonyl)phenol
2-Carbomethoxyphenol
2-Hydroxybenzoate methyl ester
2-Hydroxybenzoic acid methyl ester
Benzoic acid, 2-hydroxy-, methyl ester
Betula oil
FEMA 2745
Gaultheria oil
Hewedolor
Linsal
Methyl 2-hydroxybenzoate
Methyl 2-hydroxybenzoic acid
Methyl ester 2-hydroxy-benzoic acid
Methyl o-hydroxybenzoate
Methyl O-hydroxybenzoate
|
Methyl O-hydroxybenzoic acid
Methyl salicylate sodium salt
Methyl salicylate, 8ci
Methylsalicylate
Metsal liniment
Natural wintergreen oil
O-Hydroxybenzoic acid, methyl ester
Oil of wintergreen
Oil OF wintergreen
Rheumabal
Spicewood oil
Spicewood Oil
Sweet birch oil
Teaberry oil
|
|
94 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 2 |
|
59-30-3 |
6037
|
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
ácido fólico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
b9, Vitamin
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat b activ
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
|
Folipac
Folsaeure
Folsan
Folsaure
Folsäure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver lactobacillus casei factor
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-Pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamate
N-pteroyl-L-glutamic acid
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin b9
Vitamin B9
Vitamin Bc
Vitamin BC
Vitamin be
Vitamin Be
Vitamin m
Vitamin M
|
|
95 |
|
Pyridoxine |
Approved, Investigational, Nutraceutical, Vet_approved |
Phase 2 |
|
65-23-6 |
1054
|
Synonyms:
(5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate
12001-78-4
2B3E07D2-E4CC-4CC5-B085-6070BA01F9F0
2-methyl-3-hydroxy-4,5-bis(hydroxy-methyl) pyridine
2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin
2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin [German]
2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-Methyl-3-hydroxy-4,5-dihydroxymethylpyridine
2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine
2-methyl-4,5-dimethylol-pyridin-3-ol
3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-, hydrochloride
3-Hydroxy-2-picoline-4,5-dimethanol
3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine
3-Hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine
3-Hydroxy-4,5-dihydroxymethyl-2-methylpyridine hydrochloride
3-Hydroxy-4,5-dimethylol-.alpha.-picoline hydrochloride
3-Hydroxy-4,5-dimethylol-alpha-picoline
3-Hydroxy-4,5-dimethylol-alpha-picoline hydrochloride
3-Hydroxy-4,5-dimethylol-a-picoline
3-hydroxy-4,5-dimethylol-α-picoline
3-Hydroxy-4,5-dimethylol-α-picoline
4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol
4,5-bis(hydroxymethyl)-2-methyl-3-pyridinol hydrochloride
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol
4,5-Bis(hydroxymethyl)-2-methylpyridin-3-ol hydrochloride
4,5-bis(hydroxymethyl)-2-methylpyridine-3-ol
47862_SUPELCO
4-Deoxypyridoxine 5'-phosphate
58-56-0
58-56-0 (HCL)
58-56-0 (hydrochloride)
5-Hydroxy-6-methyl-3,4-pyridinedicarbinol hydrochloride
5-hydroxy-6-methyl-3,4-pyridinedimethanol
5-Hydroxy-6-methyl-3,4-pyridinedimethanol
5-Hydroxy-6-methyl-3,4-pyridinedimethanol hydrochloride
5-Hydroxy-6-methyl-3,4-pyridinedimethanol, hydrochloride
65-23-6
65-23-6 (Parent)
8059-24-3
85078-23-5
AC-12024
AC-14512
AC1L1AMH
AC1L1LMI
AC1L2XK2
AC1Q22HP
AC1Q2G66
AC1Q3F63
AC-907/25014218
Adermin hydrochloride
Adermine
Adermine hydrochloride
Aderomine hydrochloride
Aderoxin
Aderoxine
AI3-19016
AIDS006784
AIDS-006784
Alestrol
AR-1A6363
AR-1J1632
BB_NC-0050
Becilan
Beesix
Benadon
BIDD:PXR0180
bmse000288
Bonasanit
BPBio1_000646
BSPBio_000586
C00314
c1302
C8H11NO3
Campoviton 6
CAS-58-56-0
CBDivE_015627
CCRIS 1903
Cernevit-12
CHEBI:16709
CHEBI:30961
CHEMBL1200756
CHEMBL1364
CID104817
CID1054
CID6019
component of Alestrol
CPD0-1221
D02179
D025101
D08454
DB00165
EINECS 200-386-2
EINECS 200-603-0
EINECS 232-503-8
Godabion
Gravidox
Hexabetalin
Hexa-Betalin
Hexa-Betalin (R)
Hexa-betalin (TN)
Hexabione hydrochloride
|
Hexavibex
Hexermin
Hexermine
Hexobion
HMS1569N08
HMS2093L07
HSDB 1212
Hydoxin
I02-1897
I02-2297
KST-1A8556
LS-134393
LS-187072
LS-2332
MLS001074329
MLS002153915
MolPort-002-137-856
MolPort-002-319-991
MolPort-005-933-330
NCGC00016261-01
NCGC00164317-01
NCGC00180946-01
nchembio.93-comp1
Nestrex
NSC 36225
NSC36225
NSC36225 (HCL)
Oprea1_061614
P0561
P4722_SIAL
P5669_SIGMA
P6280_SIGMA
P8666_SIGMA
P9755_SIAL
Paxadon
Piridossina
Piridossina [DCIT]
Piridoxina
Piridoxina [INN-Spanish]
PN
PN HCl
Prestwick_925
Prestwick0_000623
Prestwick1_000623
Prestwick2_000623
Prestwick3_000623
Pydox
Pyridipca
Pyridox
Pyridoxin
Pyridoxin hydrochloride
pyridoxine
Pyridoxine
Pyridoxine (INN)
Pyridoxine [INN:BAN]
Pyridoxine chloride
Pyridoxine HCl
Pyridoxine hydrochloride
PYRIDOXINE HYDROCHLORIDE
Pyridoxine Hydrochloride (B6)
Pyridoxine hydrochloride (JP15/USP)
Pyridoxine hydrochloride [USAN:JAN]
PYRIDOXINE HYDROCHLORIDE, U.S.P.
Pyridoxine hydrogen chloride
Pyridoxine monohydrochloride
Pyridoxine, hydrochloride
Pyridoxine-HCl Microencapsulated
Pyridoxinium chloride
Pyridoxinum
Pyridoxinum [INN-Latin]
Pyridoxinum hydrochloricum
Pyridoxinum hydrochloricum (Hungarian)
Pyridoxol
Pyridoxol hydrochloride
Pyridoxol, hydrochloride
Pyridoxolum
Rodex
Rodex (R)
Rodex TD
SMP2_000230
SMR000674613
SPBio_002805
Spondylonal
STK177324
STOCK1N-08684
Tex Six T.R.
TimTec1_000657
UNII-68Y4CF58BV
UNII-KV2JZ1BI6Z
Vitamin B 6
vitamin B6
Vitamin b6
Vitamin B6
Vitamin B6-hydrochloride
Vitamin V6
Vitamin V6 (TN)
Vitamin-?B6
Vitamin-?B6 hydrochloride
Vitaped
WLN: T6NJ B1 CQ D1Q E1Q &GH
ZINC00049154
ZINC21983293
|
|
96 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 1, Phase 2 |
|
77-92-9 |
311
|
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-carboxy-3-hydroxypentane-1,5-dioic acid
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
|
Citretten
Citric acid monoglyceride
Citric acid monohydrate
Citric acid, anhydrous
Citric Acid, Anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
H3Cit
Hydrocerol a
Kyselina citronova
Monohydrate, citric acid
Suby g
Uralyt u
uro-Trainer
|
|
97 |
|
Quercetin |
Experimental, Investigational |
Phase 2 |
|
117-39-5 |
5280343
|
Synonyms:
117-39-5
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one
2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one
3,3',4',5,7-pentahydroxyflavone
3,3',4,5,7-Pentahydroxyflavone
3,3',4',5,7-Pentahydroxyflavone
3,3',4',5,7-Pentahydroxyflavone dihydrate
3,4',5,5',7-Pentahydroxy-flavone
3',4',5,7-Tetrahydroxyflavan-3-ol
3',4',5,7-tetrahydroxyflavon-3-ol
3',4',5,7-Tetrahydroxyflavon-3-ol
3,5,7,3',4'-Pentahydroxyflavone
3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on
3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-ON
3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one
3cf8
49643640-FD4C-4B93-BD28-0D7C2021CC52
5-18-05-00494 (Beilstein Handbook Reference)
7255-55-2
73123-10-1
74893-81-5
A1784/0075599
AC-19596
AC1NQWX8
AC1Q795S
AC1Q795T
ACon1_000560
AI3-26018
AKOS000511724
BAS 00649429
BIDD:ER0315
BIDD:PXR0007
Bio1_000369
Bio1_000858
Bio1_001347
Bio2_000374
Bio2_000854
BiomolKI_000062
BiomolKI2_000068
BPBio1_000477
BRD-K97399794-001-02-1
BRD-K97399794-001-07-0
BRD-K97399794-335-03-1
BRN 0317313
BSPBio_000433
BSPBio_001068
BSPBio_002243
C.I . natural yellow 10
C.I. 75670
C.I. Natural red 1
C.I. Natural Yellow 10
C.I. Natural yellow 10 & 13
C00389
CCRIS 1639
CHEBI:16243
CHEMBL50
CI 75670
CI Natural Yellow 10
CID5280343
CU-01000012502-3
Cyanidelonon 1522
D011794
DB04216
Dikvertin
DivK1c_000485
EINECS 204-187-1
EU-0100999
Flavin meletin
HMS1362F09
HMS1792F09
HMS1923O19
HMS1990F09
HMS501I07
HSDB 3529
IDI1_000485
IDI1_002129
K00029
KBio1_000485
KBio2_000408
KBio2_000584
KBio2_002976
KBio2_003152
KBio2_005544
KBio2_005720
KBio3_000775
KBio3_000776
KBio3_001463
KBioGR_000408
|
KBioGR_001293
KBioSS_000408
KBioSS_000584
KSC-10-126
KSC-23-76
KUC104418N
KUC107684N
Kvercetin
Kvercetin [Czech]
LIM-5662
LMPK12110004
LNS-5662
Lopac0_000999
Lopac-Q-0125
LS-589
LS-69030
Maybridge1_008992
MEGxp0_000381
Meletin
MixCom3_000183
MolPort-001-740-557
Natural Yellow 10
NCGC00015870-01
NCGC00015870-02
NCGC00015870-03
NCGC00015870-05
NCGC00015870-17
NCGC00025016-01
NCGC00025016-02
NCGC00025016-03
NCGC00025016-04
NCGC00025016-05
NCGC00025016-06
NCGC00025016-07
NCGC00025016-08
NCGC00168962-01
NCGC00168962-02
NCGC00168962-03
NCGC00168962-04
nchembio.117-comp3
NChemBio.2007.10-comp11
nchembio.65-comp4
NCI60_042036
NCIOpen2_007628
NCIOpen2_007882
NINDS_000485
NSC 9219
NSC324608
NSC57655
NSC58588
NSC9219
NSC-9219
P0042
Prestwick0_000507
Prestwick1_000507
Prestwick2_000507
Prestwick3_000507
Q 0125
QUE
quercetin
Quercetin content
Quercetin dihydrate
Quercetine
Quercetol
Quercitin
Quertin
Quertine
S00057
SGCUT00001
SMP1_000252
Sophoretin
SPBio_000217
SPBio_002354
Spectrum_000124
SPECTRUM1500672
Spectrum2_000059
Spectrum3_000642
Spectrum4_000807
Spectrum5_001389
STK365650
STOCK1N-04222
T-Gelb bzw. grun 1
TNP00070
TNP00089
to_000078
Tocris-1125
UNII-9IKM0I5T1E
UPCMLD-DP081
UPCMLD-DP081:001
WLN: T66 BO EVJ CR CQ DQ & DQ GQ IQ
Xanthaurine
|
|
98 |
|
Horse chestnut |
Experimental |
Phase 2 |
|
|
|
Synonyms:
|
99 |
|
Olive |
|
Phase 1, Phase 2 |
|
|
|
100 |
|
Omega 3 Fatty Acid |
|
Phase 1, Phase 2 |
|
|
|
101 |
|
Micronutrients |
|
Phase 2 |
|
|
|
102 |
|
Trace Elements |
|
Phase 2 |
|
|
|
103 |
|
Vitamins |
|
Phase 2 |
|
|
|
104 |
|
Vitamin B9 |
|
Phase 2 |
|
|
|
105 |
|
Folate |
|
Phase 2 |
|
|
|
106 |
|
Nutrients |
|
Phase 2 |
|
|
|
107 |
|
Vitamin B Complex |
|
Phase 2 |
|
|
|
108 |
|
Vitamin B 6 |
|
Phase 2 |
|
|
|
109 |
|
Butcher's Broom |
|
Phase 2 |
|
|
|
110 |
|
Citrate |
|
Phase 1, Phase 2 |
|
|
|
111 |
|
Antihypertensive Agents |
|
Phase 2 |
|
|
|
112 |
|
Adrenergic beta-Antagonists |
|
Phase 2 |
|
|
|
113 |
|
Adrenergic Antagonists |
|
Phase 2 |
|
|
|
114 |
|
Salicylates |
|
Phase 2 |
|
|
|
115 |
|
Antirheumatic Agents |
|
Phase 2 |
|
|
|
116 |
|
Pyridoxal |
Experimental, Nutraceutical |
Phase 2 |
|
66-72-8 |
1050
|
Synonyms:
2-methyl-3-hydroxy-4-formyl-5-hydroxymethylpyridine
3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde
3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde
3-HYDROXY-5-(hydroxymethyl)-2-methylisonicotinaldehyde
|
3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
3-Hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxaldehyde
Piridoxal
Pyridoxaldehyde
|
|
117 |
|
Iron |
Approved, Experimental |
|
|
15438-31-0, 7439-89-6 |
23925
27284
|
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
Ancor B
Ancor en 80/150
armco Iron
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
ATW 230
ATW 432
C00023
C3518_SIAL
C3518_SIGMA
Carbonyl iron
CCRIS 1580
CHEBI:18248
CID23925
Copy Powder CS 105-175
D007501
DB01592
Diseases (animal), iron overload
Diseases, iron overload
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Ed-In-Sol
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
Eisen
Electrolytic iron
F 60 (metal)
Fe
FE
FE (II) ion
Fe(2+)
Fe(II)
Fe1+
Fe2+
Fe-40
|
fer
Feronate
Ferretts
Ferro-Caps
Ferro-Time
Ferrous ion
ferrous iron
Ferrousal
Ferrovac e
Ferrovac E
Ferrum
Ferrum metallicum
FT 3 (element)
GS 6
Hematite
Hemocyte
HF 2 (element)
hierro
Hierro
HL (iron)
Hoeganaes ATW 230
Hoeganaes EH
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Infed
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron ion(2+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(2+)
Iron(2+) ion
Iron(II) ion
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, ion (Fe2+)
Iron, reduced
Limonite
LOHA
LS-3196
Magnetite
Malleable iron
Metopirone
Metyrapone
MolPort-003-925-001
NC 100
PZh1M1
PZh-1M3
PZh-2
PZh2M
PZH2m
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
PZHO
Reduced iron
Remko
Siderol
Suy-b 2
SUY-B 2
Taconite
UNII-E1UOL152H7
Venofer
Vitedyn-Slo
Wrought iron
Yieronia
|
|
118 |
|
Sulfadiazine |
Approved, Investigational, Vet_approved |
|
|
68-35-9 |
5215
|
Synonyms:
141582-64-1
2-Sulfanilamidopyrimidin
2-Sulfanilamidopyrimidin [German]
2-sulfanilamidopyrimidine
2-Sulfanilamidopyrimidine
2-Sulfanilamido-pyrimidine
2-sulfanilylaminopyrimidine
2-Sulfanilylaminopyrimidine
2-Sulfapyrimidine
2-Sulphanilamidopyrimidine
2-Sulphanilylaminopyrimidine
35033_FLUKA
35033_RIEDEL
4-Amino-N-(2-pyrimidinyl)benzenesulfonamide
4-amino-N-(pyrimidin-2-yl)benzenesulfonamide
4-Amino-N-2-pyrimidinyl- benzenesulfonamide
4-amino-N-2-pyrimidinylbenzenesulfonamide
4-amino-N-2-Pyrimidinylbenzenesulfonamide
4-Amino-N-2-pyrimidinyl-benzenesulfonamide
4-AMINO-N-2-PYRIMIDINYLBENZENESULFONAMIDE
4-amino-N-2-Pyrimidinylbenzenesulphonamide
4-amino-N-pyrimidin-2-ylbenzenesulfonamide
5-25-10-00067 (Beilstein Handbook Reference)
68-35-9
A 306
A-306
A-306 (VAN)
AB00052095
AC-12001
AC1L1JUR
AC1Q51XM
AC1Q6W1E
Adiazin
Adiazin, Adiazine, Debenal, Liquadiazine, Microsulfon, Sulfazine, Sulfolex, Sulfadiazine
Adiazine
AI3-01047
AKOS000119073
AR-1L4215
BB_SC-0628
BPBio1_000095
BRD-K32273377-001-05-4
BRN 0235192
BSPBio_000085
BSPBio_002884
C07658
C10H10N4O2S
CAS-68-35-9
CHEBI:9328
CHEMBL439
CID5215
Cocodiazine
CocoDiazine
Coco-Diazine
Codiazine
Cremodiazine
Cremotres
CRL-8131 & Sulfadiazine
D00587
D013411
DB00359
Debenal
Deltazina
Diazin
Diazolone
Di-Azo-Mul
Diazovit
Diazyl
DivK1c_000543
EINECS 200-685-8
Eskadiazine
HMS1568E07
HMS1921A13
HMS2090P09
HMS2092I15
HMS501L05
Honey diazine
Honey Diazine
IDI1_000543
KBio1_000543
KBio2_001466
KBio2_004034
KBio2_006602
KBio3_002104
KBioGR_000743
KBioSS_001466
Lantrisul
Lipo-Diazine
Lipo-Levazine
Liquadiazine
LS-147838
Metha-Meridiazine
Microsulfon
Mixture of sulfadiazine, sulfamerazine, and sulfamethazine
MLS000069423
MolPort-000-629-738
N(1)-2-pyrimidinylsulfanilamide
N(1)-2-Pyrimidinylsulfanilamide
N(1)-2-Pyrimidinylsulphanilamide
N(1)-2-pyrimidylsulfanilamide
N(1)-2-Pyrimidylsulfanilamide
N(1)-2-Pyrimidylsulphanilamide
N-(2-Pyrimidinyl)sulfanilamide
N(sup 1)-2-Pyrimidinylsulfanilamide
N(sup1)-2-Pyrimidinylsulfanilamide
N(sup1)-2-Pyrimidylsulfanilamide
|
N1-(Pyrimidin-2-yl)sulfanilamide
NCGC00016305-01
NCGC00016305-02
NCGC00023291-03
NCGC00023291-04
Neazine
Neotrizine
NINDS_000543
NSC 35600
NSC117870
NSC35600
Oprea1_081078
Palatrize
Pecta-Diazine
Pecta-diazine, suspension
Piridisir
Pirimal
Prestwick_428
Prestwick0_000023
Prestwick1_000023
Prestwick2_000023
Prestwick3_000023
Pyrimal
Quadetts
Quadramoid
rBPI21 & Sulfa
Recombinant bactericidal/permeability-increasing protein & Sulfadiazine
RP 2616
S. N. 112
S.N. 112
S0579
S1770_Selleck
S8626_SIGMA
Sanodiazine
SDA
Sildaflo
Silvadene
SMR000059113
Solfadiazina
Solfadiazina [DCIT]
SPBio_001417
SPBio_002006
Spectrum_000986
SPECTRUM1500546
Spectrum2_001319
Spectrum3_001362
Spectrum4_000342
Spectrum5_000992
Spofadrizine
SSD
Sterazine
STK317797
Sulfacombin
Sulfadiazene
Sulfadiazin
Sulfadiazina
Sulfadiazina [INN-Spanish]
sulfadiazine
Sulfadiazine
Sulfadiazine (JAN/USP/INN)
Sulfadiazine (TN)
Sulfadiazine [USAN:INN:JAN]
Sulfadiazine, zinc
Sulfadiazine, Zinc
Sulfadiazinum
Sulfadiazinum [INN-Latin]
Sulfaloid
Sulfanilamide, N1-2-pyrimidinyl- (8CI)
Sulfanilamidopyrimidine
Sulfapirimidin
Sulfapyrimidin
Sulfapyrimidin [German]
Sulfapyrimidine
Sulfa-Triple #2
Sulfatryl
Sulfazin
Sulfazine
Sulfolex
Sulfonamides Duplex
Sulfonsol
Sulfose
Sulphadiazin
Sulphadiazina
Sulphadiazine
Sulphadiazine E
Sulphadiazinum
Sulphapyrimidine
Terfonyl
Theradiazine
Thermazene
Thi-Di-Mer
TL80073596
Trifonamide
Triple Sulfa
Triple Sulfas
Triple Sulfoid
Trisem
Tri-Sulfameth
Trisulfapyrimidine, oral suspension
Truozine
UNII-0N7609K889
WLN: T6N CNJ BMSWR DZ
Zinc sulfadiazine
Zinc Sulfadiazine
ZINC00120319
|
|
119 |
|
Pentoxifylline |
Approved, Investigational |
|
|
6493-05-6 |
4740
|
Synonyms:
1-(5-Oxohexyl)-3,7-dimethylxanthine
1-(5-Oxohexyl)theobromine
1,2,3,6-Tetrahydro-3,7-dimethyl-1-(5-oxohexyl)-2,6-purindion
2a3c
3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl) xantine
3,7-Dimethyl-1-(5-oxohexyl)-1H,3H-purin-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
3,7-Dimethyl-1-(5-oxo-hexyl)-3,7-dihydro-purine-2,6-dione
3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione
3,7-Dimethyl-1-(5-oxohexyl)xanthine
3,7-Dimethyl-1-(5-oxohexyl)xantine
5-26-14-00081 (Beilstein Handbook Reference)
6493-05-6
AB00052363
AC1L1IUN
Agapurin
Agapurin Retard
AKOS000541484
Azupentat
BAS 00897429
BB_SC-2111
BIDD:GT0174
BL 191
BL191
BL-191
BPBio1_000167
BRD-K57569181-001-05-1
BRN 0558929
BSPBio_000151
BSPBio_003439
C07424
C13H18N4O3
CAS-1677687
CCRIS 6832
CHEMBL628
CID4740
cis-9-Octadecenoyl coenzyme A
CPD000035998
D00501
D010431
DB00806
Dimethyloxohexylxanthine
DivK1c_000729
Durapental
EHT 0201
EHT0201
EHT-0201
EHT-201
EINECS 229-374-5
EU-0100936
Hemovas
HMS1568H13
HMS1922E16
HMS2051N06
HMS2090H13
HMS2093G21
HMS502E11
I06-1592
IDI1_000729
Ikomio
IN1161
KBio1_000729
KBio2_001924
KBio2_004492
KBio2_007060
KBio3_002942
KBioGR_000893
KBioSS_001924
Lopac0_000936
|
Lopac-P-1784
LS-149385
MLS000079026
MLS000758298
MLS001201764
MolPort-001-823-263
NCGC00015801-01
NCGC00015801-02
NCGC00015801-04
NCGC00015801-10
NCGC00067069-02
NCGC00067069-03
NCGC00067069-04
NCGC00067069-05
NCGC00178062-01
NCGC00178062-02
NINDS_000729
NSC 637086
NSC637086
Oxpentifylline
P 1784
PDSP1_001015
PDSP2_000999
Pentoxifilina
Pentoxifilina [INN-Spanish]
Pentoxifyllin
pentoxifylline
Pentoxifylline
Pentoxifylline (JAN/USP/INN)
Pentoxifylline [USAN:INN:JAN]
Pentoxifyllinum
Pentoxifyllinum [INN-Latin]
Pentoxil
Pentoxil (TN)
Pentoxiphyllin
Pentoxiphylline
Pentoxiphyllium
Pentoxyfylline
PENTOXYPHYLINE
Pentoxyphyllin
Pentoxyphylline
PNX
Prestwick_608
Prestwick0_000196
Prestwick1_000196
Prestwick2_000196
Prestwick3_000196
Px
Ralofect
Rentylin
SAM001247011
SMR000035998
SPBio_001221
SPBio_002072
Spectrum_001444
SPECTRUM1503611
Spectrum2_001181
Spectrum3_001820
Spectrum4_000227
Spectrum5_001161
SR-01000075641-4
STK177321
Torental
Trental
Trental (TN)
UNII-SD6QCT3TSU
Vasofirin
Vazofirin
ZINC01530776
|
|
120 |
|
Ticlopidine |
Approved |
|
|
55142-85-3 |
5472
|
Synonyms:
5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine
5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine
55142-85-3
AC-15204
AC1L1KFB
Almirall brand OF ticlopidine hydrochloride
BIDD:PXR0169
BPBio1_000191
BRD-K00603606-003-03-4
BRN 1216802
BSPBio_000173
C07140
C14H14ClNS
CAS-53885-35-1
CHEBI:9588
CHEMBL833
CID5472
D08594
DB00208
EINECS 259-498-5
HMS2089I18
Hydrochloride, ticlopidine
L001108
LS-152434
MLS001201825
MolPort-002-507-849
NCGC00016872-01
NCGC00016872-02
NCGC00024361-04
|
PCR 5332
Prestwick0_000047
Prestwick1_000047
Prestwick2_000047
Prestwick3_000047
Roche brand OF ticlopidine hydrochloride
SMR000641861
SPBio_002094
STK589340
STOCK5S-54105
Ticlid
Ticlodix
Ticlodone
Ticlopidina
Ticlopidina [INN-Spanish]
ticlopidine
Ticlopidine
Ticlopidine (INN)
Ticlopidine [INN:BAN]
Ticlopidine HCL
Ticlopidine hydrochloride
Ticlopidine Hydrochloride
Ticlopidin-Puren
Ticlopidin-Puren (TN)
Ticlopidinum
Ticlopidinum [INN-Latin]
UNII-OM90ZUW7M1
UNM-0000345023
Vitoria brand OF ticlopidine hydrochloride
ZINC19594599
|
|
121 |
|
Aspirin |
Approved, Vet_approved |
|
|
50-78-2 |
2244
|
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoate
2-(ACETYLOXY)benzoIC ACID
2349-94-2
26914-13-6
2-Acetoxybenzenecarboxylate
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. empirin
A.S.A. Empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acid, acetylsalicylic
Acide 2-(acetyloxy)benzoique
acide 2-(acétyloxy)benzoïque
Acide acetylsalicylique
Acide acétylsalicylique
acido Acetilsalicilico
Acido acetilsalicilico
ácido acetilsalicílico
Acido O-acetil-benzoico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
AI3-02956
AIN
AKOS000118884
Aloxiprimum
ASA
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspirdrops
aspirin
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina
Aspirina 03
Aspirine
Aspir-Mox
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bialpirina
Bialpirinia
BIDD:GT0118
Bi-prin
BRN 0779271
Bufferin
C01405
Caprin
Cardioaspirin
Cardioaspirina
CCRIS 3243
Cemirit
CHEBI:15365
CHEMBL25
CID2244
Claradin
Clariprin
cMAP_000006
Colfarit
component of Midol
component of Synirin
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
Easprin
Easprin (TN)
ECM
Ecolen
Ecotrin
EINECS 200-064-1
Empirin
|
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EU-0100038
Extren
Globentyl
Globoid
Helicon
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
I14-7505
IDI1_000555
Idragin
Istopirin
Kapsazal
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
Levius
Lopac0_000038
Lopac-A-5376
LS-143
Magnecyl
Measurin
Medisyl
Micristin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
nchem.859-comp6
NCI60_002222
Neuronika
NINDS_000555
Novid
NSC 27223
NSC27223
NSC406186
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-accetylsalicylic acid
O-Acetoxybenzoate
o-acetoxybenzoic acid
o-Acetoxybenzoic acid
O-Acetoxybenzoic acid
O-Acetylsalicylate
O-acetylsalicylic acid
O-Acetylsalicylic acid
o-carboxyphenyl acetate
o-Carboxyphenyl acetate
O-Carboxyphenyl acetate
O-Carboxyphenyl acetic acid
Persistin
Pharmacin
Pirseal
PL-2200
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
Salacetin
Salcetogen
Saletin
Salicylate acetate
Salicylic acid acetate
Salicylic acid acetic acid
Salicylic acid, acetate
Salospir
SMR000059138
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
SP 189
SPBio_001838
Spectrum_001245
SPECTRUM1500130
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
ST075414
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII=R16CO5Y76E
UNII-R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
Xaxa
XAXA
Yasta
Zorprin
ZORprin
|
|
122 |
|
Hyaluronic acid |
Approved, Vet_approved |
|
|
9004-61-9 |
53477741
|
Synonyms:
|
123 |
|
Silicon |
Approved, Investigational |
|
|
7440-21-3 |
4082203
|
Synonyms:
|
Silicate
Silicic acid
silicio
|
|
124 |
|
Copper |
Approved, Investigational |
|
|
7440-50-8 |
27099
|
Synonyms:
cobre
COPPER (II) ion
Copper(II) cation
Copper, ion (cu2+)
Cu
Cu(2+)
|
Cu(II)
Cu2+
cuivre
Cupric ion
cuprum
Kupfer
|
|
125 |
|
Warfarin |
Approved |
|
|
81-81-2 |
6691
54678486
|
Synonyms:
(-)-Warfarin
(Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
(S)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone
(S)-Warfarin
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
200 coumarin
200 Coumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
45706_FLUKA
45706_RIEDEL
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
4oh-Coumarin deriv.
5543-56-6
5543-57-7
81-81-2
A2250_FLUKA
A2250_SIGMA
AC-15978
AC1L1N37
AC1Q6AN3
aldo Brand OF warfarin sodium
Aldocumar
Antigen brand OF warfarin sodium
Apotex brand OF warfarin sodium
apo-Warfarin
AR-1E2310
Arab rat death
Arab Rat Death
Arab rat deth
Athrombin
Athrombine-K
Athrombin-K
Bailly brand OF warfarin sodium
Bio-0586
Boots brand OF warfarin sodium
BRD-A24514565-001-02-2
BRD-A24514565-236-01-6
Bristol-myers squibb brand OF warfarin sodium
BRN 1293536
Brumolin
BSPBio_002026
C01541
C19H16O4
Caswell No. 903
CBDivE_002127
CBDivE_013236
CBKinase1_000192
CBKinase1_012592
CHEBI:10033
CHEMBL1464
Choice
Choice (TN)
CID6691
Compound 42
Co-Rax
CO-Rax
Coumadin
Coumadin Tabs
Coumadine
Coumafen
Coumafene
Coumafene [French]
Coumaphen
Coumaphene
Coumarins
Coumefene
Cov-R-tox
Cov-R-Tox
D08682
DB00682
D-Con
D-CON
delta-CON
Dethmor
Dethnel
Dicusat e
Dicusat E
DivK1c_000444
DL-3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
Eastern states duocide
EINECS 201-377-6
EINECS 226-907-3
EPA Pesticide Chemical Code 086002
Estedi brand OF warfarin sodium
fasco Fascrat powder
Fasco fascrat powder
Frass-ratron
Frass-Ratron
Genpharm brand OF warfarin sodium
Gen-warfarin
Goldshield brand OF warfarin sodium
HMS1921K07
HMS2092C20
HMS501G06
HSDB 1786
I14-0958
IDI1_000444
Jantoven
KBio1_000444
KBio2_000674
KBio2_003242
KBio2_005810
KBio3_001526
KBioGR_000901
KBioSS_000674
Killgerm sewarin P
Kumader
Kumadu
Kumatox
Kypfarin
Latka 42
Latka 42 [Czech]
Liqua-tox
LS-55083
Maag rattentod cum
Maag Rattentod Cum
Marevan
Mar-frin
Mar-Frin
|
Martin's mar-frin
Martin'S mar-frin
Maveran
MLS001304042
MolPort-001-787-822
Mouse pak
NCGC00094810-01
NCGC00094810-02
NCGC00159398-03
NCGC00178855-01
nchembio.307-comp19
NINDS_000444
NSC 59813
NSC59813
Panwarfin
Place-pax
Place-Pax
Potassium, warfarin
Prothromadin
PS104_SUPELCO
rac-Warfarin
Rat & mice bait
Rat and mice bait
Rat-alpha-way
Rat-a-way
Rat-beta-gon
Rat-b-gon
Rat-B-gon
Rat-gard
Rat-Gard
Rat-kill
Rat-Kill
Rat-mix
Rat-Mix
Rat-o-cide #2
Rat-O-cide #2
Rat-O-cide no. 2
Rat-ola
Rat-Ola
Ratorex
Ratox
Ratoxin
Ratron
Ratron g
Ratron G
Rats-no-more
Rats-NO-more
Ratten-koederrohr
Ratten-Koederrohr
Rattenstreupulver neu schacht
Rattenstreupulver Neu Schacht
Rattenstreupulver new schacht
Rattentraenke
Rat-trol
Rat-Trol
Rattunal
RAX
RCR Grey squirrel killer concentrate
RCRA waste no. P001
Rcra waste number P001
Rodafarin
Rodafarin c
Rodafarin C
ro-Deth
Ro-Deth
Rodex
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
Sakarat
Sewarin
SMP1_000316
SMR000718754
Sodium, warfarin
Sofarin
Solfarin
Sorexa plus
Sorexa Plus
SPBio_000870
Spectrum_000194
SPECTRUM1500613
Spectrum2_000935
Spectrum3_000583
Spectrum4_000381
Spectrum5_001751
Spray-trol brand roden-trol
STK364490
Tedicumar
Temus W
Tintorane
Tox-hid
Tox-Hid
Twin light rat away
UNII-5Q7ZVV76EI
Vampirinip II
Vampirinip iii
Vampirinip III
W.A.R.F. 42
Waran
Warf 10
Warf 42
WARF compound 42
Warfant
Warfarat
warfarin
Warfarin
Warfarin (and salts of)
Warfarin (INN)
Warfarin [BSI:ISO]
Warfarin [INN:BAN]
Warfarin plus
Warfarin Plus
Warfarin plus [discontinued]
Warfarin potassium
Warfarin Q
Warfarin sodium
Warfarin titrated to an INR of 2.5-3.0
Warfarin(R)
Warfarina
Warfarina [INN-Spanish]
Warfarine
Warfarine [INN-French]
Warfarine [ISO-French]
Warfarinum
Warfarinum [INN-Latin]
Warficide
Warfilone
WLN: T66 BOVJ DYR&1V1 EQ
Zoocoumarin
Zoocoumarin [Netherlands and USSR]
Zoocoumarin [Russian]
|
|
126 |
|
Polidocanol |
Approved |
|
|
9002-92-0 |
|
Synonyms:
Aethoxy-sklerol
Laureth 9
Laureth-9
Macrogol 9 lauryl ether
Nonaethylene glycol monododecyl ether
|
Nonaethylene glycol monolauryl ether
PEG-9 lauryl ether
Polydocanol
Polyethylene glycol 450 lauryl ether
Polyoxyl 9 lauryl ether
|
|
127 |
|
Amikacin |
Approved, Investigational, Vet_approved |
|
|
37517-28-5 |
37768
|
Synonyms:
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-(3-amino-3-deoxy-alpha-D-glucopyranosyloxy)-4-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-3-hydroxycyclohexyl]-2-hydroxybutanamide
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
(2S)-4-amino-N-{(1R,2S,3S,4R,5S)-5-amino-2-[(3-amino-3-deoxy-alpha-D-glucopyranosyl)oxy]-4-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanamide
108914-65-4
110660-81-6
110660-83-8
111319-93-8
1-N-(L(-)-g-amino-a-Hydroxybutyryl)kanamycin a
1-N-(L(-)-gamma-amino-alpha-Hydroxybutyryl)kanamycin a
1-N-(L(-)-gamma-Amino-alpha-hydroxybutyryl)kanamycin A
1-N-(L(-)-γ-amino-α-hydroxybutyryl)kanamycin a
1-N-(L(−)-γ-amino-α-hydroxybutyryl)kanamycin A
37517-28-5
38859-32-4
A.M.K
AB00513828
AC1L1YE8
AC1Q5JTM
Amicacin
Amiglyde-V
amikacin
Amikacin
Amikacin & Tumor Necrosis Factor
Amikacin (USP)
Amikacin (USP/INN)
Amikacin [USAN:BAN:INN]
Amikacin base
Amikacin Base
Amikacin dihydrate
Amikacin Dihydrate
Amikacin sulfate
Amikacin Sulfate
AMIKACIN SULFATE
Amikacina
Amikacina [INN-Spanish]
Amikacina medical
Amikacina normon
amikacine
Amikacine
Amikacine [INN-French]
Amikacinum
Amikacinum [INN-Latin]
Amikafur
Amikalem
Amikason's
Amikavet
Amikayect
Amikin
Amikin (Disulfate)
Amiklin
Amukin
Antibiotic BB-K 8
ANTIBIOTIC BB-K8
Apothecon brand OF amikacin sulfate
Arikace
BB K 8
BB K8
|
BBK 8
BB-K 8
BBK8
BB-K8
Biclin
Biklin
BPBio1_000671
Briclin
Bristol myers squibb brand OF amikacin sulfate
Bristol-myers squibb brand OF amikacin sulfate
BSPBio_000609
C06820
C22H43N5O13
CHEBI:2637
CHEMBL177
CID37768
Collins brand OF amikacin sulfate
Cryopharma brand OF amikacin sulfate
D02543
DB00479
EINECS 253-538-5
Fustery brand OF amikacin sulfate
Galen brand OF amikacin sulfate
Gamikal
Grossmann brand OF amikacin sulfate
HSDB 3583
Kaminax
Kanbine
Lemery brand OF amikacin sulfate
LS-146896
Lukadin
Mead johnson brand OF amikacin sulfate
Medical brand OF amikacin sulfate
Medical, amikacina
Mikavir
MolPort-000-761-900
NCGC00093350-02
NCGC00093350-03
Norman brand OF amikacin sulfate
Normon, amikacina
NSC 177001
NSC177001
O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-1-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine
O-3-amino-3-Deoxy-a-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-a-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
O-3-amino-3-Deoxy-alpha-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
O-3-amino-3-Deoxy-α-D-glucopyranosyl-(1->4)-O-(6-amino-6-deoxy-α-D-glucopyranosyl-(1->6))-N(3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
Oprad
Pisa brand OF amikacin sulfate
Prestwick3_000395
Rovi brand OF amikacin sulfate
Son's brand OF amikacin sulfate
STK039706
Sulfate, amikacin
UNII-84319SGC3C
Yectamid
|
|
128 |
|
Teicoplanin |
Approved, Investigational |
|
|
61036-62-2 |
|
Synonyms:
Teichomycin A2
Teicoplanin
teicoplanina
|
téicoplanine
teicoplaninum
|
|
129 |
|
Polihexanide |
Approved, Investigational |
|
|
28757-47-3 |
|
Synonyms:
Polyhexamethylene biguanide
|
|
|
130 |
|
Rivaroxaban |
Approved |
|
|
366789-02-8 |
|
Synonyms:
|
131 |
|
fluindione |
Approved, Investigational |
|
|
957-56-2 |
|
132 |
|
Apixaban |
Approved |
|
|
503612-47-3 |
10182969
|
Synonyms:
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd
2p16
503612-47-3
AKOS005146204
Apixaban
apixabán
Apixaban (JAN/USAN/INN)
apixabanum
BMS 562247-01
BMS-562247
BMS-562247-01
|
BMS-562247-01, Apixaban
CHEBI:49620
CHEMBL231779
CID10182969
D03213
DB07828
Eliquis
GG2
ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide
S1593_Selleck
UNII-3Z9Y7UWC1J
|
|
133 |
|
Castor oil |
Approved, Investigational, Nutraceutical, Vet_approved |
|
|
8001-79-4 |
|
Synonyms:
Agaliya oil
Bimayou
Castorbean oil
Cataputia major oil
Cataputia minor oil
Croton spinosus oil
Lama palagi oil
Maskerekur oil
Oleum ricini
Ricinus africanus oil
Ricinus angulatus oil
Ricinus armatus oil
Ricinus atropurpureus oil
Ricinus badius oil
Ricinus borboniensis oil
Ricinus cambodgensis oil
Ricinus communis (castor) seed oil
Ricinus communis castor seed oil
Ricinus communis fibre oil
Ricinus communis oil
Ricinus communis seed oil
Ricinus compactus oil
Ricinus digitatus oil
Ricinus europaeus oil
Ricinus gibsonii oil
Ricinus giganteus oil
Ricinus glaucus oil
Ricinus hybridus oil
Ricinus inermis oil
Ricinus japonicus oil
Ricinus krappa oil
Ricinus laevis oil
|
Ricinus lividus oil
Ricinus macrocarpus oil
Ricinus macrophyllus oil
Ricinus medicus oil
Ricinus medius oil
Ricinus messeniacus oil
Ricinus metallicus oil
Ricinus microcarpus oil
Ricinus minor oil
Ricinus nanus oil
Ricinus obermannii oil
Ricinus oil
Ricinus peltatus oil
Ricinus perennis oil
Ricinus persicus oil
Ricinus purpurascens oil
Ricinus ruber oil
Ricinus rugosus oil
Ricinus rutilans oil
Ricinus sanguineus oil
Ricinus scaber oil
Ricinus speciosus oil
Ricinus spectabilis oil
Ricinus tunisensis oil
Ricinus undulatus oil
Ricinus urens oil
Ricinus viridis oil
Ricinus vulgaris oil
Ricinus zanzibarensis oil
Ricinus zanzibarinus
Toto ni vavalagi oil
Uluchula skoki oil
|
|
134 |
|
Tribenoside |
Experimental |
|
|
10310-32-4 |
|
Synonyms:
|
135 |
|
Dabigatran |
Investigational |
|
|
211914-51-1 |
|
Synonyms:
|
136 |
|
Monensin |
Experimental, Vet_approved |
|
|
17090-79-8 |
|
Synonyms:
Monensic acid
Monensin
Monensin A
|
|
|
137 |
|
Castor |
|
|
|
|
|
138 |
|
Antitubercular Agents |
|
|
|
|
|
139 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
|
|
|
|
140 |
|
Chlorhexidine gluconate |
|
|
|
|
|
141 |
|
Antibodies |
|
|
|
|
|
142 |
|
Immunoglobulins |
|
|
|
|
|
143 |
|
Antibodies, Antiphospholipid |
|
|
|
|
|
144 |
|
Antidotes |
|
|
|
|
|
145 |
|
Anti-Bacterial Agents |
|
|
|
|
|
146 |
|
Anti-Infective Agents, Local |
|
|
|
|
|
147 |
|
Antibiotics, Antitubercular |
|
|
|
|
|
148 |
|
Anti-Infective Agents |
|
|
|
|
|
149 |
|
Complement System Proteins |
|
|
|
|
|
150 |
|
Charcoal |
|
|
|
|
|
151 |
|
Carbopol 940 |
|
|
|
|
|
152 |
|
Anesthetics, General |
|
|
|
|
|
153 |
|
Cathartics |
|
|
|
|
|
154 |
|
Laxatives |
|
|
|
|
|
155 |
|
Analgesics |
|
|
|
|
|
Interventional clinical trials:
(showing 229, show less)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A 6-week, Open, Multicentre Safety Trial to Evaluate the Tolerability Profile of Antistax® Film Coated Tablets (Extr. Vitis Viniferae Siccum), 360 mg/Day Per os, in Male and Female Patients Suffering From Chronic Venous Insufficiency |
Completed |
NCT02184234
|
Phase 4 |
Antistax film coated tablets |
2 |
Evaluate the Efficacy and Safety of Esarin Gel in the Treatment of Chronic Venous Insufficiency or Varicose Vein Combine With Superficial Vein Thrombophlebitis in Outpatient |
Completed |
NCT02346058
|
Phase 4 |
Esarin Gel |
3 |
The Fate Of Calf Perforators After Endovenous Laser Ablation Of Saphenous Veins |
Completed |
NCT01458795
|
Phase 4 |
|
4 |
Multicenter, Prospective, Randomized, Double-Blind Study to Assess the Therapeutic Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Venous Insufficiency |
Completed |
NCT00835822
|
Phase 4 |
Venocur Triplex®;placebo |
5 |
Gliding Aids for Medical Compression Stockings - Practicability in Elderly Patients With Chronic Venous Insufficiency |
Completed |
NCT01432795
|
Phase 4 |
|
6 |
Evaluation of Efficacy and Safety of the Fixed-dose Combination of Coumarin and Troxerutin (Venalot®) Versus Placebo in the Symptomatic Treatment of Chronic Venous Insufficiency - VENACT |
Completed |
NCT01848210
|
Phase 4 |
Coumarin/troxerutin;Placebo |
7 |
Randomized Double-blind Trial Between Clinical and Endovascular Treatment in Patients With Advanced Chronic Venous Insufficiency and Iliac Venous Obstruction |
Completed |
NCT02149212
|
Phase 4 |
Phlebotonic |
8 |
Clinical Non-inferiority Study Between Diosmin 600 mg Tablets and Diosmin 900 mg + Hesperidin 100 mg Tablets in Symptomatic Chronic Venous Insufficiency After 6 Months of Treatment: Single-blind, Randomized, Parallel Group Study |
Completed |
NCT03471910
|
Phase 4 |
Diosmin;Diosmin / Hesperidin |
9 |
SocknLeg - a User Friendly Medical Compression Study of a Modified Application of a Medical Device |
Completed |
NCT02621632
|
Phase 4 |
|
10 |
The Effect of Neuromuscular Electrical Therapy on Pain in Patients With Venous Ulcers: a Controlled Clinical Trial |
Completed |
NCT01372020
|
Phase 4 |
|
11 |
Radiofrequency Ablation vs Laser Ablation of the Incompetent Greater Saphenous Vein: A Prospective Randomized Trial |
Completed |
NCT02236338
|
Phase 4 |
|
12 |
A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers |
Completed |
NCT01743053
|
Phase 4 |
|
13 |
Polidocanol Versus Glucose For Sclerotherapy Treatment Of Telangiectasia Of The Lower Limbs: Protocol For A Randomized, Controlled Clinical Trial |
Completed |
NCT02657252
|
Phase 4 |
Glucose;Polidocanol with Glucose |
14 |
A Randomized Triple-blind Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Sclerotherapy in Treatment of Reticular Veins at the Lower Limbs. |
Completed |
NCT02054325
|
Phase 4 |
Polidocanol with Glucose;Glucose |
15 |
Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism Event |
Recruiting |
NCT03988101
|
Phase 4 |
Rosuvastatin 20mg;Control |
16 |
The Efficacy of Rivaroxaban With Diosmine in the Long-term Treatment of Acute Proximal Deep Vein Thrombosis |
Active, not recruiting |
NCT03413618
|
Phase 4 |
Rivaroxaban;Diosmin |
17 |
A Randomised Clinical Trial Comparing Endovenous Laser Ablation and Mechanochemical Ablation (ClariVein®) in the Management of Superficial Venous Insufficiency |
Active, not recruiting |
NCT02627846
|
Phase 4 |
Lidocaine with 1:200,000 epinephrine solution;Lidocaine with 1:200,000 epinephrine solution;Sodium Bicarbonate;Sodium Tetradecyl Sulphate |
18 |
Study of Antiinflammatory Effects of Detralex (Daflon) in Patients With Chronic Venous Disease |
Enrolling by invitation |
NCT01654016
|
Phase 4 |
Detralex |
19 |
Radiofrequency Ablation vs. Laser Ablation of the Incompetent Small Saphenous Vein: A Prospective Randomized Trial |
Terminated |
NCT02248740
|
Phase 4 |
|
20 |
Prospective Evaluation of the Quality of Life of Patients With Post-thrombotic Syndrome Who Receive Compression Therapy and Sulodexide — SQUARES Study |
Terminated |
NCT02512601
|
Phase 4 |
Sulodexide |
21 |
A Randomized Trial of the Flexitouch Compression System as an Adjunctive Treatment for Venous Stasis Ulcer |
Terminated |
NCT00534937
|
Phase 4 |
|
22 |
A Randomised Clinical Trial Comparing Standard Cannula Delivered Foam Sclerotherapy, Catheter Directed Foam Sclerotherapy and ClariVein® Mechanochemical Ablation in the Management of Superficial Venous Insufficiency. |
Withdrawn |
NCT02010437
|
Phase 4 |
Sodium Tetradecyl Sulphate (STS) |
23 |
A Clinical Multicenter, Phase III, Prospective, Randomized, Double-blind, Comparative Study to Evaluate the Efficacy and Tolerability of Venaflon Use in Reducing the Symptoms Caused by Chronic Venous Insufficiency When Compared With Daflon |
Unknown status |
NCT01477281
|
Phase 3 |
Daflon;Venaflon (Diosmin and Hesperidin) |
24 |
Study Clinical, Multicenter,Phase III,Prospective,Randomized,Comparative Double Blind/Double-dummy to Assess the Efficacy and Tolerability of the Use of Varicell in Reducing the Symptoms Caused by Chronic Venous Insufficiency and Hemorrhoidal Syndrome When Compared With Daflon |
Unknown status |
NCT01321619
|
Phase 3 |
Daflon;Varicell placebo |
25 |
Comparative Efficacy of Two Preparations of the Association Diosmin (450 mg) + Hesperidin (50 mg) in the Treatment of Chronic Venous Insufficiency (CVI) |
Unknown status |
NCT01110512
|
Phase 3 |
Flavonid;Daflon |
26 |
A Comparative Study to Assess the Efficacy and Safety of Endolex Forte vs Diosmin and Hesperidin in Reducing the symptomatoLogy of Patients With ChronIc VeNous Insufficiency Between Functional Classes CEAP 1-4, During a Period of 6 Months |
Unknown status |
NCT02927483
|
Phase 3 |
|
27 |
A Prospective, Multi-Centre, Double Blind, Randomized, Placebo Controlled Trial to Evaluate the Safety and Efficacy of ICXP007 in a Phase III Trial With Four-Layer Therapeutic Compression, for the Treatment of Non-Infected Skin Leg Ulcers, Due to Venous-Insufficiency |
Unknown status |
NCT00232973
|
Phase 3 |
ICXP007 |
28 |
Efficacy of Autologous Platelet-Rich Plasma in the Treatment of Vascular Ulcers in Primary Care: Clinical Trial Phase III |
Unknown status |
NCT02213952
|
Phase 3 |
Platelet-Rich Plasma |
29 |
Randomized Single Center Comparative Study of the Treatment of Insufficient Greater Saphenous Vein: Surgery vs Ultrasound Guided Sclerotherapy With Foam and Endovenous Laser Therapy |
Unknown status |
NCT00529672
|
Phase 3 |
|
30 |
A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial to Evaluate Efficacy and Tolerability of Antistax Film-coated Tablets, 360 mg/Day Orally, in Male and Female Patients Suffering From Chronic Venous Insufficiency. |
Completed |
NCT00292435
|
Phase 3 |
Read vine leaf extract (AS 195) |
31 |
A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial to Evaluate Efficacy and Tolerability of Antistax® Film Coated Tablets, 360 mg/Day Orally, in Male and Female Patients Suffering From Chronic Venous Insufficiency |
Completed |
NCT02191254
|
Phase 3 |
Antistax®;Placebo |
32 |
Prospective, Randomized and Explorative Controlled Study About Influences of Compression Stockings on Skin's Barrier Function at Patients With Chronic Venous Insufficiency |
Completed |
NCT00196443
|
Phase 2, Phase 3 |
|
33 |
A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial to Evaluate Efficacy and Tolerability of Antistax® Film Coated Tablets, 720 mg/Day Orally, in Male and Female Patients Suffering From Chronic Venous Insufficiency |
Completed |
NCT00855179
|
Phase 3 |
Red vine leaf extract (AS 195);Placebo |
34 |
Clinical Study of BNS003 on Swelling Due to Disorder of Leg Venous Reflux |
Completed |
NCT02211898
|
Phase 3 |
BNS003 |
35 |
Evaluation of the Efficacy of Spa Treatment for Prevention of Leg Ulcers in Advanced Chronic Venous Insufficiency. |
Completed |
NCT00838500
|
Phase 3 |
Immediate spa treatment;Late spa treatment |
36 |
Crenobalneotherapy in the Treatment of Chronic Venous Insufficiency. A Randomized Clinical Trial. |
Completed |
NCT01956318
|
Phase 3 |
|
37 |
Efficacy on Volume Reduction and Tolerance of Progressiv' Medical Compressive Therapy (MCT) V0322 BC in Patients With Chronic Venous Oedema. International, Multicentric, Randomised, Controlled, Double Blind Study, in Two Parallel Groups v0322 bc Versus Placebo |
Completed |
NCT01402921
|
Phase 3 |
|
38 |
Treatment of Greater Saphenous Vein (GSV) Insufficiency Using Echo-Guided Sclerotherapy With Lauromacrogol 400 Foam –Comparative Study of 3% Versus 1% Concentration. |
Completed |
NCT00348764
|
Phase 3 |
lauromacrogol |
39 |
Deep Venous Thrombosis. Long-Term Results After Treatment With Either Low-Molecular -Weight Heparin or Unfractionated Heparin. Examinations of the Venous System. |
Completed |
NCT00628576
|
Phase 3 |
unfractionated heparin;Tinzaparin (Leo) |
40 |
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 |
Completed |
NCT01737762
|
Phase 3 |
|
41 |
Double Blind Randomized Controlled Trial of Recombinant Human Platelet Derived Growth Factor-BB Gel (Regranex Gel®) Versus Hydrogel (Duoderm Hydrogel®) for Healing of MARTORELL's Hypertensive Leg Ulcers. ERAN Trial. |
Completed |
NCT00970697
|
Phase 3 |
becaplermin gel;Duoderm Hydrogel™ |
42 |
Zoledronic Acid or Methylprednisolone in the Management of Active Charcot's Neuroarthropathy of Foot in Patients With Diabetes Mellitus: A Randomized, Double-blind, Placebo Controlled Trial |
Completed |
NCT03289338
|
Phase 2, Phase 3 |
Zoledronic Acid;Methylprednisolone;Placebos |
43 |
Double Blind, Randomized, Placebo Controlled Clinical Trial for the Treatment of Diabetic Foot Ulcers, Using a Nitric Oxide Releasing Patch: PATHON |
Completed |
NCT00428727
|
Phase 3 |
Controlled nitric oxide releasing patch;placebo patch |
44 |
The MUFFIN-PTS Trial: Micronized Purified Flavonoid Fraction for the Treatment of Post-Thrombotic Syndrome |
Not yet recruiting |
NCT03833024
|
Phase 3 |
Micronized Purified Flavonoid Fraction;Placebo |
45 |
A Phase 3 Randomized Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (EU) |
Terminated |
NCT01853384
|
Phase 3 |
|
46 |
Clinical Evaluation of the Safety and Effectiveness of Topical Autologous Platelet Gel (APG) for the Treatment of Lower Extremity Chronic Venous Insufficiency Ulcers. A Multicenter, Randomized, Controlled Clinical Trial |
Withdrawn |
NCT00273234
|
Phase 3 |
|
47 |
Endovenous Treatment of the Saphenous Vein With Biolitec 1470nm Laser Versus Vnus Closure Fast |
Unknown status |
NCT01972633
|
Phase 1, Phase 2 |
|
48 |
Phase 1 and 2 Study on the Efficacy and Side Effects of Olive Oil and Omega 3 Local Treatment in Stasis Dermatitis |
Unknown status |
NCT00421161
|
Phase 1, Phase 2 |
olive oil and omega 3 in a combined cream |
49 |
A Prospective Double Blind Randomized Controlled Trial Of Electrocoagulation Versus Radiofrequency Treatment Of The Great Saphenous Vein In Patients With Varicose Veins. |
Unknown status |
NCT02139085
|
Phase 2 |
|
50 |
Efficacy Study of a Peristaltic Pulse Pneumatic Device in the Treatment of Claudication |
Unknown status |
NCT01007604
|
Phase 2 |
|
51 |
NON-HEALING ULCERS WITHOUT CRITICAL LIMB ISCHEMIA (NEWLI-Trial): A Single Center Pilot Trial on the Efficacy of an Endovascular Approach for Treatment of Non-healing Lower Limb Ulcers in Patients Presenting With a Mild to Moderate Peripheral Artery Disease |
Unknown status |
NCT01666093
|
Phase 2 |
|
52 |
An Open-label, Non-randomized, Phase I/II Study of Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UC-MSC) and Liberation Therapy (When Associated With Chronic Cerebrovascular Venous Insufficiency) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) |
Unknown status |
NCT02587715
|
Phase 1, Phase 2 |
|
53 |
A Phase II Randomized Study to Evaluate the Safety of the Compression Test Device Using Intermittent Pneumatic Compression Mode in Subjects With Venous Insufficiency and Oedema |
Completed |
NCT00732823
|
Phase 2 |
|
54 |
The Ability of Antistax® to Improve Chronic Venous Insufficiency (CVI) I and II in Male and Female Patients: a Dose Response Study |
Completed |
NCT02191280
|
Phase 2 |
Antistax®, low dose;Antistax®, high dose;Placebo |
55 |
A 17 Week, Randomised, Double-blind, Placebo Controlled Cross-over Trial to Evaluate the Efficacy of Antistax® Film Coated Tablets (Extr. Vitis Vinifera Siccum), 360 mg/Day p.o. in Improving Microcirculation of the Skin in the Leg of Male and Female Patients Suffering From Chronic Venous Insufficiency |
Completed |
NCT02191163
|
Phase 2 |
Antistax®;Placebo |
56 |
Endovascular Correction of Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Evaluation of Influence of These Treatments on the Symptoms of Multiple Sclerosis |
Completed |
NCT01264848
|
Phase 1, Phase 2 |
|
57 |
Physical Conditioning in Management of Chronic Venous Insufficiency |
Completed |
NCT00013273
|
Phase 2 |
|
58 |
Evaluation of DermStream(tm) - an Irrigation Product for Chronic Wound Management |
Completed |
NCT00310752
|
Phase 1, Phase 2 |
|
59 |
Phase I/II Interventional Clinical Trial of Balloon Venoplasty for Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis Patients |
Completed |
NCT01864941
|
Phase 1, Phase 2 |
|
60 |
A Randomized, Parallel Group, Controlled Study to Assess the Efficacy and Safety of NMBM in the Treatment of Subjects With a Post-cellulitis and Venous Leg Ulcer |
Completed |
NCT01770509
|
Phase 1, Phase 2 |
|
61 |
The Efficacy of Red Vine Leaf Extract, Butcher's Broom, Horse Chestnut and Vitamin B6 on the Quality of Life in Females With Chronic Venous Insufficiency |
Completed |
NCT02498327
|
Phase 2 |
|
62 |
The Efficacy of Red Vine Leaf Extract, Butcher's Broom, Horse Chestnut and Vitamin B6 in the Treatment of Symptoms Associated With Chronic Venous Insufficiency |
Completed |
NCT02483962
|
Phase 2 |
|
63 |
Topical Timolol Benefit in Venous Ulcers |
Completed |
NCT02422017
|
Phase 2 |
Timolol |
64 |
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients With Venous Stasis Ulcers |
Completed |
NCT00832091
|
Phase 2 |
Thymosin Beta 4;Placebo |
65 |
Preventing Venous Leg Ulcers With Cryotherapy: A Randomized Clinical Trial |
Completed |
NCT01509599
|
Phase 1, Phase 2 |
|
66 |
Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers Compared to Moist Wound Care in a Primary Care Setting |
Completed |
NCT01817218
|
Phase 1, Phase 2 |
Platelet Rich Plasma |
67 |
Micro-mobile Foot Compression Device to Improve Motor-function in People With Diabetes and Loss of Protective Sensation |
Completed |
NCT03135535
|
Phase 2 |
|
68 |
Safety and Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Chronic Soft Tissue Wounds |
Completed |
NCT00545896
|
Phase 2 |
|
69 |
An Open Label Multicenter Safety Study of the Varisolve® Procedure for the Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt |
Completed |
NCT00442364
|
Phase 2 |
Polidocanol (1%) Microfoam (Varisolve) |
70 |
Community Randomised Control Trial of the Effectiveness of Two Compression Bandaging Technologies |
Completed |
NCT00202267
|
Phase 2 |
|
71 |
A Prospective, Randomized, Controlled, Multi-Center, Double Blind Study of ClariVein RES for Treatment of Venous Insufficiency Associated With Incompetent Saphenous Veins Due to Superficial Venous Reflux |
Recruiting |
NCT03311269
|
Phase 2 |
Sodium Tetradecyl Sulfate 1% Injection;Sodium Tetradecyl Sulfate 3% Injection |
72 |
Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers: a Two-arm, Double-blind, Placebo-controlled, Randomized Controlled Trial. |
Recruiting |
NCT03154619
|
Phase 2 |
0.1% TR 987;Placebo gel |
73 |
Novel Offloading for Diabetic Foot Ulcers With PulseFlow: A Prospective Study |
Recruiting |
NCT02783066
|
Phase 2 |
|
74 |
Monitoring and Managing Newly Healed Chronic Leg and Foot Ulcer Skin Temperature: A Cooling Intervention (MUSTCOOL) to Prevent Ulcer Recurrence |
Recruiting |
NCT02626156
|
Phase 2 |
|
75 |
A PRELIMINARY OPEN CLINICAL STUDY, TO ASSESS THE SAFETY AND EFFICACY OF RPh201 APPLIED TOPICALLY FOR THE TREATMENT OF HARD TO HEAL CHRONIC ULCERATED WOUNDS |
Terminated |
NCT01429519
|
Phase 1, Phase 2 |
RPh201, botanical drug product |
76 |
An Open-label, Non-randomized, Phase I/II Study of Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UC-MSC) and Liberation Therapy (When Associated With Chronic Cerebrovascular Venous Insufficiency) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) |
Terminated |
NCT02418325
|
Phase 1, Phase 2 |
|
77 |
A Phase 1a, Open Label, Single Dose, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Normal Volunteers Given Punch Skin Biopsies |
Unknown status |
NCT00916292
|
Phase 1 |
FGF-1 141;FGF-1 141 |
78 |
Study on the Effect of Kinesio Taping on Bioelectrical Activity of Gastrocnemius Muscles and Range of Ankle Motion in Post-menopausal Women With Chronic Venous Insufficiency |
Completed |
NCT01501188
|
Phase 1 |
|
79 |
Deep Diabetic Foot Wound Treatment With Hydrogel Including 3% Sodium Pentaborate Pentahydrate |
Recruiting |
NCT02241811
|
Phase 1 |
3% Sodium Pentaborate Pentahydrate;Placebo |
80 |
Phase I Open-label, First-in-human Study to Evaluate Feasibility and Safety of Tissue Engineered Veins in Patients With Chronic Venous Insufficiency |
Not yet recruiting |
NCT03784131
|
Phase 1 |
P-TEV |
81 |
The Clinical Research of Surgery on Primary Chronic Venous Insufficiency |
Unknown status |
NCT00931424
|
|
|
82 |
Compliance of Compression Therapy in Healed Venous Ulcerations |
Unknown status |
NCT01680809
|
|
|
83 |
REVITIVE for the Treatment of Patients With Venous Insufficiency |
Unknown status |
NCT02114307
|
|
|
84 |
A Confirmatory Study to Evaluate the Safety and Efficacy of Cryopreserved Bilayered Cellular Matrix (ORCEL) for the Treatment of Venous Ulcers |
Unknown status |
NCT00270972
|
|
|
85 |
Venous Pressure Measurement of the Great Saphenous Vein Using Controlled Compression Ultrasound in Healthy Persons and Patients With Chronic Venous Disease as a New Non Invasive Method for Investigation of the Pathophysiology in Primary Varicose Veins |
Unknown status |
NCT01000909
|
|
|
86 |
Safety and Primary Efficacy of the External Synchronized Vein Valve (ESVV) in Treatment of Chronic Venous Insufficiency (CVI) Sequel - A Pilot Study |
Unknown status |
NCT01346553
|
|
|
87 |
Venous Obstruction in Neurodegenerative Disorders Research Registry |
Unknown status |
NCT01593358
|
|
|
88 |
3-4 Year Outcomes Following Endovenous Steam Ablation of the Saphenous Veins for the Treatment of Venous Insufficiency |
Unknown status |
NCT02944331
|
|
|
89 |
Prospective Multicentric Randomised Trial Between Radiofrequency Ablation With VNUS Closure Fast ® and Endovenous Ablation With 1470 nm Diod Laser and Tulip Fiber ® for Treatment of Primary Venous Insufficiency. |
Unknown status |
NCT01722019
|
|
|
90 |
Prospective, Single-arm, Single Center, Pilot Study of Vascular Ultrasound Imaging Used as an Adjunct to Intravascular Ultrasound for Diagnosing Iliac Vein Obstruction |
Unknown status |
NCT02240914
|
|
|
91 |
Aqua Therapy to Lower Adverse and Negative Effects of Deep Vein ThrombosIs and Post Thrombotic Syndrome |
Unknown status |
NCT02553720
|
|
|
92 |
Radiographic and Intravascular (IVUS) Evaluation of Venous Morphology During CCSVI Treatment |
Unknown status |
NCT01593891
|
|
|
93 |
Development and Validation of a Limb Volumetry Technique Applicable in Daily Clinical Practice Using Self Positioning 3D Laser Scanning:Reproductibility and Comparison to the Reference Method |
Unknown status |
NCT01574911
|
|
|
94 |
Clinical Trial : Terminal Axial Perforator Interruption Reflux Source (TAPIRS ) Plus Adjustable Compression System in Treatment of Venous Leg Ulcers Versus Multilayer Bandage Treatment |
Unknown status |
NCT02798445
|
|
|
95 |
Color Doppler U/S vs MSCT Venography in the Diagnosis of May-Thurner Syndrome |
Unknown status |
NCT03262987
|
|
|
96 |
Local Endogenous Biomarkers in the Later Stages of Chronic Venous Disease Versus Controls During Gravitational Stress, Prolonged Elevation Recovery and Compression |
Unknown status |
NCT02662127
|
|
|
97 |
Vascular Abnormalities in Idiopathic Parkinson's Disease |
Unknown status |
NCT02045420
|
|
|
98 |
Study to Evaluate Polyheal-1 in Treatment of Recalcitrant Wounds |
Unknown status |
NCT00552643
|
|
|
99 |
Randomized Clinical Trial to Determinate the Effectiveness and Safety of Plasma Rich Growth Factors (PRGF) in Venous Ulcers Treatment |
Unknown status |
NCT01491438
|
|
|
100 |
Non-Invasive Management of Chronic Venous Insufficiency |
Completed |
NCT00950378
|
|
|
101 |
Manual Lymphatic Drainage in Chronic Venous Insufficiency: a Randomized Controlled Trial |
Completed |
NCT01899482
|
|
|
102 |
The Effects of Compression Stockings on Pressure Parameters in Patients With Chronic Venous Insufficiency |
Completed |
NCT01558024
|
|
|
103 |
Transient Elastography DEdicated to Cosmetology And Dermatology (TEDECAD) |
Completed |
NCT02061254
|
|
|
104 |
Doppler Sonography, Magnetic Resonance Venography, Air-plethysmography in the Non-invasive Diagnostics of Chronic Cerebrospinal Venous Insufficiency (CCSVI) |
Completed |
NCT01425554
|
|
|
105 |
Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort |
Completed |
NCT02015221
|
|
|
106 |
The Effectiveness of Exercise Training in Venous Insufficiency |
Completed |
NCT03755180
|
|
|
107 |
Single Center Prospective Study Evaluating the Safety of Progressive Compressive Stockings for the Treatment of Venous Insufficiency in Patients With Peripheral Arterial Disease |
Completed |
NCT02431819
|
|
|
108 |
Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings: A Randomized Pilot Study |
Completed |
NCT01793194
|
|
|
109 |
Obtaining and Storing Blood Samples and Debridement Samples for Wound Related Research |
Completed |
NCT00762697
|
|
|
110 |
The Sapheon Closure System Feasibility Study |
Completed |
NCT01603433
|
|
|
111 |
Dosing of Electrical Stimulation in Venous Insufficiency |
Completed |
NCT03850496
|
|
|
112 |
New Combined Laser Therapy in Patients With Trophic Ulcers of Lower Extremities and Chronic Venous Insufficiency |
Completed |
NCT03104985
|
|
|
113 |
Comparative Randomized Clinical Study to Evaluate the Efficacy of Radiofrequency vs Surgical Technique of Internal Saphenous Vein Stripping and CHIVA Technique in the Treatment of Chronic Venous Insufficiency. |
Completed |
NCT02454452
|
|
|
114 |
A Comparison of the Party Balloon Assisted Valsalva With Conventional Valsalva Maneuver in Diagnosis of Superficial Venous Valvular Reflux of Lower Limb |
Completed |
NCT02051439
|
|
|
115 |
IN-BALANCE VLU Inflammation, Bacteria, & Angiogenesis Effects in Launching Venous Leg Ulcer Healing |
Completed |
NCT01549860
|
|
|
116 |
Vascular Fundus Changes in Patients With High Probability of CCSVI (Chronic Cerebrospinal Venous Insufficiency) |
Completed |
NCT01356134
|
|
|
117 |
The Utility of Novel Ambulatory Treatment Techniques in Venous Insufficiency |
Completed |
NCT01298908
|
|
|
118 |
Fibered Platinum Coils vs Vascular Plugs in Pelvic Varices Embolization for the Treatment of Pelvic Congestion Syndrome |
Completed |
NCT02796092
|
|
|
119 |
Lake Washington Vascular VenaSeal™ Post-Market Evaluation: WAVES |
Completed |
NCT02585726
|
|
|
120 |
Cross-Sectional Population Based Study on Prevalence and Risk Factors for Chronic Venous Disease in General Population |
Completed |
NCT03900234
|
|
|
121 |
A Retrospective Analysis of Patients With Full Thickness Wounds in Limbs With Critical Ischemia |
Completed |
NCT00760357
|
|
|
122 |
Safety and Wound Healing Efficacy of the TalidermR Wound Dressing a Poly-N-acetyl Glucosamine-derived Membrane Material in Humans With Venous Stasis Ulcers: a Pilot Study. |
Completed |
NCT00720239
|
Early Phase 1 |
|
123 |
Clinical Aspect of Erosive Pustular Dermatosis of the Leg |
Completed |
NCT03623191
|
|
|
124 |
Post Market Study - "European Observational Study of the Sapheon™ Closure System for the Definitive Treatment of Incompetent Great Saphenous Veins: A Prospective Single Arm Multicenter Clinical Observational Study" |
Completed |
NCT01570101
|
|
|
125 |
SOCKNLEG Compression Stocking Kit User Friendliness: Donning-Doffing-Edema Prevention An Open Monocentric Randomized Controlled Cross-over Trial |
Completed |
NCT03429959
|
|
|
126 |
Randomized Multi-centered Study for Evaluating the Efficacy and Safety of Angioplastic Surgery of the Extracranial Veins in the Treatment of Multiple Sclerosis. Studio Randomizzato Multicentrico Per la Valutazione Dell'Efficacia e Sicurezza Dell'Intervento di Disostruzione Delle Vene Extracraniche Nel Trattamento Della Sclerosi Multipla |
Completed |
NCT01371760
|
|
|
127 |
Effectiveness of a Pressure Indicator Guided and a Conventional Bandaging in Treatment of Venous Leg Ulcer |
Completed |
NCT02729688
|
|
|
128 |
Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort in Patients With Venous Leg Ulcers |
Completed |
NCT02395302
|
|
|
129 |
Intermittent, Gradient, Pneumatic Compression Plus Standard Compression for Hard-To-Heal Venous Ulcers in Subjects With Secondary Lymphedema and Chronic Venous Insufficiency |
Completed |
NCT01079299
|
|
|
130 |
Chronic Venous Insufficiency; Impact of Compression Stockings on Quality of Life |
Completed |
NCT02050061
|
|
|
131 |
Feasibility, Efficacy, and Safety of Venous Ulcer Treatment Using a Hand Plasma Generator (PlasmaDerm) Chronisch venöser Ulzerationen (PlasmaDerm) |
Completed |
NCT01415622
|
|
|
132 |
Venous Insufficiency and Neuromuscular Stimulation |
Completed |
NCT02137499
|
|
|
133 |
Compression Therapy Versus Surgery in the Treatment of Superficial Venous Reflux - A Randomized Controlled Trial |
Completed |
NCT01701661
|
|
|
134 |
Prevalence of Chronic Cerebrospinal Venous Insufficiency in Patients With Multiple Sclerosis and Other Neurological Diseases. An Ultrasound, Blinded, Case-Controlled, Centralized Reading Assessment |
Completed |
NCT02308579
|
|
|
135 |
Evaluation of Electrocardiographic Guidance in Accurate Peripherally Inserted Central Catheter Placement in Children. |
Completed |
NCT02324504
|
|
|
136 |
LivRelief Varicose Veins Cream in the Treatment of Chronic Venous Insufficiency of the Lower Limbs: A 6-week Single Arm Pilot Study |
Completed |
NCT03653793
|
|
|
137 |
Incidence and Progression of Peripheral Venous Disease |
Completed |
NCT00508079
|
|
|
138 |
Randomised Trial of Radiofrequency Ablation vs Conventional Surgery for Superficial Venous Insufficiency: if You Don't Tell, They Won't Know |
Completed |
NCT02588911
|
|
|
139 |
A Dual Centre, Randomised Controlled Trial of the Clinical and Cost Effectiveness of Endovenous Laser Therapy (EVLT) in the Treatment of Varicose Veins and Venous Ulcers |
Completed |
NCT00759434
|
|
|
140 |
A Prospective Epidemiological Multicenter Cohort Study on Patients Clinically Suspected of Deep Vein Thrombosis or Pulmonary Embolism |
Completed |
NCT00670540
|
|
|
141 |
Association of Thrombophilia and Inflammation With Post-Thrombotic Syndrome |
Completed |
NCT00395265
|
|
|
142 |
Optimal Intensity and Frequency of a Portable Electrical Muscle Stimulator (VeinoPlus) to Improve Symptoms of Postthrombotic Syndrome |
Completed |
NCT00858130
|
|
|
143 |
Open Label Clinical Study to Assess the Clinical Safety of a New Compression Procedure in Subjects With Peripheral Arterial Vascular Disease |
Completed |
NCT00854516
|
|
|
144 |
Prevalence of Onychodystrophy in Patients With Chronic Venous Disease of the Lower Limbs |
Completed |
NCT02731222
|
|
|
145 |
Randomized Clinical Trial of Routine Preoperative Duplex Imaging Before Varicose Vein Surgery; Long-term Follow-up |
Completed |
NCT01195623
|
|
|
146 |
Carbon Dioxide Infusion:Clinical and Histological Appraisal in Chronic Wounds |
Completed |
NCT01864967
|
|
|
147 |
Cryotherapy for Chronic Venous Disorders |
Completed |
NCT00617825
|
|
|
148 |
Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins The RELIEVE Study |
Completed |
NCT00565604
|
|
|
149 |
Prospective Evaluation of the Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers |
Completed |
NCT00709631
|
|
|
150 |
Prospective Random Study for Handling Venous Ulcer With Conservative Treatment (Dressings Alone) and Foam Sclerotherapy Versus Conservative Treatment |
Completed |
NCT01594658
|
|
|
151 |
Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia ("POTS" -- Postural Orthostatic Tachycardia Syndrome)Later in Life -- a Retrospective Analysis |
Completed |
NCT01367977
|
|
|
152 |
Impact of Copper Compression Stockings on Venous Insufficiency and Lipodermatosclerosis: a Randomised Controlled Trial |
Completed |
NCT03283800
|
|
|
153 |
Prospective Interventional Study Investigating the Effect of Renal Transplantation on Obstructive Sleep Apnea and Its Correlation to Nocturnal Rostral Fluid Shift, in End Stage Renal Disease Patients |
Completed |
NCT02020642
|
|
|
154 |
The Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran- a Cross-Sectional Assessment of RE-COVER Study Patients |
Completed |
NCT03050138
|
|
|
155 |
Effect of Intermittent Hemodialysis on Sleep Apnea Syndrome and Its Correlation to Nocturnal Rostral Fluid Shift, in End Stage Renal Disease Patients |
Completed |
NCT01860209
|
|
|
156 |
Blood Flow and Bone Density in Healthy Adult Women |
Completed |
NCT00397462
|
|
|
157 |
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon |
Completed |
NCT02683408
|
|
|
158 |
Observational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative Diseases |
Completed |
NCT01384825
|
|
|
159 |
The Effect of Compression Stockings on Cerebral Desaturation Events in Obese Patients Undergoing Shoulder Arthroscopy in the Beach Chair Position |
Completed |
NCT01996813
|
|
|
160 |
Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice |
Completed |
NCT02266771
|
|
|
161 |
A Prospective, Randomized, Controlled Clinical Study to Evaluate the Effectiveness of a Cellulose Matrix Wound Dressing for Autolytic Debridement and Healing of Chronic Venous Ulcers |
Completed |
NCT00446823
|
|
|
162 |
State-of-the Art Treatment of Chronic Leg Ulcers: a Randomised Controlled Trial Comparing Vacuum Assisted Closure (V.A.C.®) With Modern Wound Dressings |
Completed |
NCT00243620
|
|
|
163 |
Quadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS) |
Completed |
NCT02907411
|
|
|
164 |
Non-invasive Measurement of Microvascular Blood Flow During Mild External Compression of the Leg |
Completed |
NCT01804478
|
|
|
165 |
Activated Carbon Interphase Effect on Biofilm and Total Bacterial Load: A Randomized Pilot Study |
Completed |
NCT03461783
|
|
|
166 |
Multi-Screen Electronic Alert for Venous Thromboembolism Prevention |
Completed |
NCT00550082
|
|
|
167 |
Observational Study of the Effect of VarIthena® on Wound Healing in the Treatment of Venous Leg Ulcers Resulting From Chronic Venous Insufficiency |
Recruiting |
NCT03257254
|
|
Varithena |
168 |
Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System |
Recruiting |
NCT03216005
|
|
|
169 |
Lower Limb Venous Insufficiency and the Effect of Radiofrequency Treatment Versus Open Surgery. A 5-year Follow-up Using Duplex Ultrasound, Plethysmography, VCSS, AVVQ and EQ-5D |
Recruiting |
NCT02397226
|
|
|
170 |
VEINEX : Venous Investigations During Exercise |
Recruiting |
NCT02689557
|
|
|
171 |
Discovering the Effect of Venous Insufficiency on Nocturia (DEVINe - Trial) - Pilootstudie: definiëren Van Duidelijke Afkapwaarden Omtrent Oedeem Ter Hoogte Van de Onderste Ledematen te Gevolge Van Veneuze insufficiëntie. |
Recruiting |
NCT03928197
|
|
|
172 |
SOCKNLEG Leg Compression Stocking Kit: Physical Properties: Static Stiffness Index - Venous Ejection Fraction An Open Monocentric Randomized Controlled Cross-over Trial |
Recruiting |
NCT03743597
|
|
|
173 |
Venous Ulcer: Endovenous Radiofrequency Treatment of Insufficient Perforating and Saphenous Veins Versus Multilayer Compression Bandaging - Randomized Controlled Clinical Trial |
Recruiting |
NCT03293836
|
|
|
174 |
Immediate Versus Early Endovenous Ablation In Venous Ulcer |
Recruiting |
NCT03795064
|
|
Sodium Tetradecyl Sulfate |
175 |
The Effect of Structured Exercise on Chronic Venous Insufficiency: A Feasibility Trial |
Recruiting |
NCT03562546
|
|
|
176 |
Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis: A Bayesian Adaptive Randomized Trial |
Recruiting |
NCT03368313
|
|
|
177 |
Long Term Natural History of PTS and Other Adverse Outcomes After Venous Thromboembolism in the Optimev Study (SPOT) |
Recruiting |
NCT03054727
|
|
|
178 |
Volume Estimation of Lower Limbs Before and After Endovascular Venous Intervention or Conventional Surgery in Venous Disease |
Recruiting |
NCT03703765
|
|
|
179 |
Randomized Controlled Trial Comparing the Clinical Outcomes After Cyanoacrylate Closure and Surgical Stripping for Incompetent Saphenous Veins |
Recruiting |
NCT03835559
|
|
|
180 |
A Real World, Observational Registry of Chronic Wounds and Ulcers to Assess Quality of Care, Evidence Based Practice and Outcomes Using Linked Electronic Health Record Data |
Recruiting |
NCT02280733
|
|
|
181 |
Platelet Rich Fibrin in Combination With Topical Antibiotics or Antiseptics in the Treatment of Chronic Wounds - a Prospective, Randomized, Active Controlled, Double Blind Pilot Trial With an Observer-blinded Control Group |
Recruiting |
NCT02652169
|
|
PRF mixed with amikacin and teicoplanin;PRF mixed with PHMB plus Macrogolol;PRF plus normal saline |
182 |
A Single Centre Open Label Study Measuring Microcirculatory Flux Using Speckle Imaging Device, in Patients With Arterial, Mixed and Diabetic Foot Ulcers Using gekoTM Neuromuscular Electrostimulation (NMES) |
Recruiting |
NCT03186560
|
|
|
183 |
Monitoring of Tissue Transfer Flaps by Modulated Imaging (MI) Spectroscopy |
Recruiting |
NCT00633503
|
|
|
184 |
Assessment of Tissue and Biomolecular Complements of Lower Limb Chronic Oedema |
Recruiting |
NCT02914808
|
|
|
185 |
A Randomised Controlled Trial of Compression Stockings Therapy Following Mechano-Chemical Ablation |
Recruiting |
NCT03685838
|
|
|
186 |
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial |
Recruiting |
NCT03250247
|
|
|
187 |
The Difference in Wound Size Reduction Comparing Two Frequently Used Wound Dressings in Everyday Care - a Randomized Controlled Trail |
Recruiting |
NCT03596112
|
|
|
188 |
A Sham Controlled Study to Compare the Effectiveness of Three Different Power Levels of PEMF Devices in the Treatment and Resolution of Venous Stasis Leg Ulcers |
Recruiting |
NCT03416049
|
|
|
189 |
Multi-center Study on the Effectiveness of Treatment With a Blue Light Medical Device (EmoLED) in Reduction of the Ulcer Surface in 10 Weeks |
Recruiting |
NCT04018924
|
|
|
190 |
Pain in Patients With Chronic Leg and Foot Ulcers - a Cross Sectional Study |
Recruiting |
NCT03086577
|
|
|
191 |
A Single Center, Prospective, Double-blinded, Randomized, Placebo-controlled Trial Evaluating the Efficacy of Fractionated Carbon Dioxide Therapy in Postoperative Lower Extremity Wound Healing |
Recruiting |
NCT03644849
|
|
|
192 |
Pilot Randomised Controlled Trial Evaluating the Potential Benefit of a One Stop Vein Clinic (OSVeC) |
Recruiting |
NCT02557542
|
|
Foam sclerotherapy (Polidocanol or Sodium Tetradecyl Sulphate) |
193 |
Open Label, Prospective Clinical Trial to Evaluate Impact on Quality of Life in Chronic Venous Insufficiency Patients Using SANKOM® Patent Socks During 4 Weeks |
Active, not recruiting |
NCT03445091
|
|
|
194 |
Prospective Safety and Effectiveness Study: VenaCure Endovenous Laser Treatment (EVLT) 400 µm Fiber Procedure Kit for Treatment of Incompetent Perforator Veins |
Active, not recruiting |
NCT02215369
|
|
|
195 |
A Randomised Controlled Trial of the Clinical and Cost Effectiveness of Endovenous Laser Therapy in the Treatment of Varicose Veins Secondary to Isolated Sapheno-Popliteal Incompetence and Short Saphenous Reflux |
Active, not recruiting |
NCT00841178
|
|
|
196 |
Randomized Trial Comparing a Dual Action Pneumatic Compression System Against Multi-Layer Bandaging Systems: A Non-inferiority Study |
Active, not recruiting |
NCT02680834
|
|
|
197 |
Multi-Centre Registry to Investigate the Efficacy and Safety of Venaseal Endovenous Ablation for Varicose Veins in Singapore |
Active, not recruiting |
NCT03893201
|
|
|
198 |
A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck Treatment |
Active, not recruiting |
NCT03332160
|
|
|
199 |
A Prospective, Multi-Center, Randomized, Parallel-group Study Comparing AMNIOEXCEL Plus Placental Allograft Membrane to a Marketed Comparator and Standard of Care Procedures in the Management of Diabetic Foot Ulcers |
Active, not recruiting |
NCT03547635
|
|
|
200 |
Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome |
Active, not recruiting |
NCT02148029
|
|
|
201 |
Outpatient Office Based Endovascular Procedures |
Enrolling by invitation |
NCT04054440
|
|
|
202 |
Effect of Plasma Derived Exosomes on Intractable Cutaneous Wound Healing: Prospective Trial |
Enrolling by invitation |
NCT02565264
|
Early Phase 1 |
|
203 |
Venaseal Versus Ablation With Endothermal Laser or Radiofrequency for Saphenous Vein Incompetence: a Comparison of Utilization of Adjunctive Phlebectomy |
Enrolling by invitation |
NCT04006184
|
|
|
204 |
A Prospective Randomized Clinical Trial Comparing Multi-layer Bandage Compression Therapy With and Without a Biologically Active Human Skin Allograft for the Treatment of Chronic Venous Leg Ulcers |
Enrolling by invitation |
NCT03935386
|
|
|
205 |
A Prospective Randomized Comparative Parallel Study of Amniotic Membrane in the Management of Venous Leg Ulcerations |
Enrolling by invitation |
NCT02929056
|
|
|
206 |
The Effectiveness of Trans-catheter Foam Sclerotherapy of Pelvic and Atypical Lower Limb Varicosities |
Not yet recruiting |
NCT03652025
|
|
|
207 |
Cyanoacrylate Closure for Treatment of Venous Leg Ulcers |
Not yet recruiting |
NCT04011371
|
|
|
208 |
Ecchymosis and Coldness in Patients With Varicose Vein: Multicenter Study of Modified VEIN-Sym QoL Assessment |
Not yet recruiting |
NCT03384355
|
|
|
209 |
EdemaWear to Reduce Edema in Hospitalized Patients With Chronic Venous Insufficiency: A Pilot Study |
Not yet recruiting |
NCT03904602
|
|
|
210 |
A Comparative Evaluation of a Marine Polysaccharide Dressing and a Carboxymethylcellulose Dressing on Subjects With Lower Extremity Venous Ulcers |
Not yet recruiting |
NCT03903692
|
|
|
211 |
Genital Haemorrhage in Woman of Childbearing Age Treated for Venous Thromboembolism Disease : Comparison According to Oral Anticoagulant and Impact on Quality of Life. |
Not yet recruiting |
NCT03772366
|
|
|
212 |
Endovasculer Treatement of Male Pelvic Venous Insufficiency |
Not yet recruiting |
NCT03341897
|
|
|
213 |
Role of Intravascular Ultrasound(IVUS) in Management of Acute and Chronic Iliocaval Obstruction |
Not yet recruiting |
NCT04024215
|
|
|
214 |
Multi-center Registry for CCSVI Testing and Treatment |
Suspended |
NCT01205633
|
|
|
215 |
A Prospective Multicenter Study on the Treatment of Incompetent Perforators With the VNUS® Closure Radiofrequency Stylet |
Terminated |
NCT01079598
|
|
|
216 |
A Feasibility Study of the InterVene ReLeaf Catheter System in the Creation of Tissue Leaflets in the Femoral and/or Popliteal Vein |
Terminated |
NCT02462096
|
|
|
217 |
Utility of Chronic Cerebrospinal Venous Insufficiency Percutaneous Angioplasty for Multiple Sclerosis: The Albany Vascular Group Study (Liberation Study) |
Terminated |
NCT01089686
|
|
|
218 |
The Effectiveness of Endovascular Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Patients With Multiple Sclerosis |
Terminated |
NCT01201707
|
|
|
219 |
Treatment of Chronic Wounds Using Extracellular Matrix-Based Devices and the Patient's Own Blood Components |
Terminated |
NCT01909908
|
|
|
220 |
Evaluation of GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface for the Treatment of Venous Occlusions and Stenoses |
Terminated |
NCT01406795
|
|
|
221 |
Evaluation of Perivascular Venous Vascularization and Inflammation by Contrast-enhanced Ultrasound (CEUS) in Patients With Acute Deep Vein Thrombosis and Superficial Thrombophlebitis - a Pilot Study |
Terminated |
NCT01367769
|
|
|
222 |
A Multi-center Randomized Open-Label Controlled Clinical Trial Evaluating Suction Blister Grafting Utilizing a Novel Harvesting Device (CelluTome©) and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers |
Terminated |
NCT02148302
|
|
|
223 |
Impact of 3-week SPA Therapy on Sleep Apnea in Patients With Obstructive Sleep Apnea Syndrome and Chronic Venous Insufficiency: A Randomized, Controlled Study |
Withdrawn |
NCT02559427
|
|
|
224 |
A Multi-Center, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Subjects Comparing the NeverTouch Versus the RF ClosureFAST Methods of Treatment of the Great Saphenous Vein |
Withdrawn |
NCT01173419
|
|
|
225 |
The Effect of Percutaneous Venoplasty on Muscular Function, Mobility and Fatigue of Multiple Sclerosis (MS) Patients With Chronic Cerebrospinal Venous Insufficiency (CCSVI). |
Withdrawn |
NCT01555684
|
|
|
226 |
Does Minimal Post-operative Compression Affect the Outcome for Endovenous Ablation in Treating Varicose Vein Patients? |
Withdrawn |
NCT02241707
|
|
|
227 |
Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting. |
Withdrawn |
NCT02936271
|
|
|
228 |
Treatment of Chronic Wound Staphylococcus Aureus Biofilms With Staphylococcus Epidermidis Esp Protein to Promote Healing |
Withdrawn |
NCT01646502
|
|
|
229 |
Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life -- a Retrospective Analysis |
Withdrawn |
NCT01377805
|
|
|
Inferred drug relations via
UMLS
72
/
NDF-RT
51
:
Gotu Kola Extract
GOTU KOLA LIQUID
|
Polidocanol
|
|